US20010020132A1 - Spectroscopic system employing a plurality of data types - Google Patents
Spectroscopic system employing a plurality of data types Download PDFInfo
- Publication number
- US20010020132A1 US20010020132A1 US09/738,613 US73861300A US2001020132A1 US 20010020132 A1 US20010020132 A1 US 20010020132A1 US 73861300 A US73861300 A US 73861300A US 2001020132 A1 US2001020132 A1 US 2001020132A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- test specimen
- specimen
- test
- spectrum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0062—Arrangements for scanning
- A61B5/0068—Confocal scanning
Definitions
- This invention relates generally to spectroscopic systems. More particularly, in one embodiment, the invention relates to a spectroscopic system for characterizing test specimens using a plurality of spectral data types.
- Spectral analysis of biological specimens has been used for disease diagnosis.
- spectra are recorded as values of amplitude, typically measured as a response to an excitation, as a function of wavelength (or the inverse of wavelength, namely frequency).
- different kinds of information are conveyed by different spectral types.
- fluorescence spectra are recorded using a source of excitation illumination that is absorbed by a specimen and that causes the specimen to emit a fluorescence spectrum that depends in part on the transfer of energy within and among atoms and/or molecules in the specimen.
- An illumination source for use in observing and recording fluorescence spectra generally operates at a selected monochromatic wavelength, or a narrow range of wavelengths.
- a fluorescence spectrum can depend on both the excitation wavelength that is used to illuminate a specimen and on the composition of the specimen itself.
- Other effects also play a role in determining a fluorescence spectrum, for example, instrumental effects, effects relating to polarization of the illumination, or thermal effects.
- the invention provides methods of determining the disease state of a biological specimen based upon a reflectance spectrum residual derived by subtracting from a reflectance spectrum obtained from a test specimen an average reflectance spectrum obtained from a plurality if healthy specimens.
- members of the plurality of healthy specimens are determined to be healthy based upon the fluorescence spectra emitted by those samples.
- the specimen to be tested exhibits a fluorescence spectrum that is not characteristic of healthy tissue.
- the reflectance spectrum residual provides a criterion for diagnostic classification of a specimen that is judged to be indeterminate in classification by its fluorescence spectrum alone.
- methods of the invention resolve diagnostic ambiguities created when a specimen produces a fluorescence spectrum that is not characteristic of a healthy tissue. Similarly, methods of the invention are also useful to resolve diagnostic ambiguities created when the fluorescence spectrum of a test specimen is not characteristic of any known disease state.
- the invention provides a method of determining a condition of a test specimen.
- the method comprises recording both fluorescence and reflectance spectra from specific specimen.
- the method then comprises identifying a plurality of specimens having a fluorescence spectrum characteristic of a known condition; obtaining an average reflectance spectrum based upon the plurality of first test specimens; obtaining a reflectance spectrum from a test specimen that produces a fluorescence spectrum that is not characteristic of the known condition; and obtaining a reflectance spectrum residual by subtracting the average reflectance spectrum from the reflectance spectrum obtained from the test specimen. Determination of the condition of the test specimen is based upon the reflectance spectrum residual.
- condition of the test specimen is based upon an amplitude of one or more features of the reflectance spectrum residual.
- a “condition” is a state of disease, including a healthy state or simply the physiological makeup of the specimen and/or the patient from whom it was obtained.
- the plurality of specimens producing the average reflectance spectrum comprises tissue specimens and the test specimen is a tissue specimen of the same type.
- the tissue specimens are human cervical tissue specimens, the condition of which is healthy, and the condition of the test specimen is determined by methods of the invention.
- cervical tissue producing the average reflectance spectrum are selected from normal squamous tissue, metaplasia, mile cervical intraepithelial neoplasia (CIN I), and moderate to severe cervical intraepithelial neoplasia (CIN II/III).
- methods of the invention further comprise obtaining additional optical information from the test specimen, and evaluating the additional optical information in comparison to the fluorescence spectrum and the reflectance spectrum from the test specimen to determine the condition of the test specimen.
- the additional optical information is video information.
- the additional optical information is an optical image.
- the invention relates to a spectroscopic system for determining a condition of a test specimen.
- the system comprises a data collection module that collects a fluorescence spectrum characteristic of a known condition from each of a plurality of first specimens, observes a reflectance spectrum from each member of the plurality, and observes a reflectance spectrum from a test specimen that is observed to produce a second fluorescence spectrum that is not characteristic of the known condition.
- the system further comprises a computation module that computes an average reflectance spectrum based upon each member of the plurality of first specimens, and that computes a reflectance spectrum residual by subtracting the average reflectance spectrum from the reflectance spectrum obtained from a test specimen, and an analysis module that determines the condition of the test specimen based at least in part upon the reflectance spectrum residual.
- FIG. 1 shows an exemplary spectroscopic system that employs a plurality of spectral types according to an illustrative embodiment of the invention
- FIG. 2 shows an exemplary operational block diagram of the spectroscopic system of FIG. 1;
- FIG. 3 is a detailed schematic flow diagram showing exemplary steps of combining a fluorescence spectrum analysis described more fully in FIG. 6 with a reflectance spectrum analysis described more fully in FIG. 7 to perform tissue characterization according to an illustrative embodiment of the invention
- FIG. 4 is a diagram showing an exemplary fluorescence spectrum recorded using the spectroscopic system of FIG. 1;
- FIG. 5 is a diagram showing an exemplary reflectance spectrum recorded using the spectroscopic system of FIG. 1;
- FIG. 6 is a schematic flow diagram depicting an analysis of a fluorescence spectrum in a system according to an illustrative embodiment of the invention.
- FIG. 7 is a schematic flow diagram depicting an analysis of a reflectance spectrum in a system according to an illustrative embodiment of the invention.
- the invention relates to the use of multiple types of spectral data for determining the status of a test specimen.
- a first spectral observation is used to distinguish between a first condition and a plurality of other conditions
- a second observation using information obtained from a different type of spectral data is used to distinguish among the plurality of other conditions.
- the invention will be described in terms of embodiments that relate to the use of multiple optical spectra in characterization systems and methods, particularly in the area of medical diagnostics, and especially as such use relates to the analysis of spectra obtained from human cervical tissue in the detection of cervical cancer.
- the invention has applicability generally in the area of characterization of test specimens based on analysis of a plurality of optical spectra types.
- FIG. 1 depicts an exemplary spectroscopic system 100 employing a plurality of spectral data types in methods and systems according to an illustrative embodiment of the invention.
- the spectroscopic system includes a console 102 connected to a probe 104 by a cable 106 .
- the cable 106 carries electrical and optical signals between the console 102 and the probe 104 .
- the probe 104 accommodates a disposable component 108 which used only once, and discarded after such use.
- the console 102 and the probe 104 are mechanically connected by an articulating arm 11 0 , which can also support the cable 106 .
- the console 102 contains much of the hardware and the software of the system, and the probe 104 contains the necessary hardware for making suitable spectroscopic observations. The details of the system are further explained in conjunction with FIG. 2.
- FIG. 2 shows an exemplary operational block diagram 200 of a spectroscopic system of the type depicted in FIG. 1.
- the spectroscopic system of FIGS. 1 and 2 is subtantially the same as single-beam spectrometer devices, but is adapted to include the features of the invention.
- the console 102 includes a computer 202 which executes 5 software that controls the operation of the spectroscopic system 100 .
- the software includes one or more modules recorded on machine-readable media, which can be any medium such as magnetic disks, magnetic tape, CD-ROM, semiconductor memory, or the like.
- the machine-readable medium is resident within the computer 202 .
- the machine-readable medium can be connected to the computer 202 by a communication link.
- firmware i.e., computer instructions recorded on devices such as PROMs, EPROMS oe EEPROMs, or the like.
- machine-readable instructions as used herein is intended to encompass software, hardwired logic, firmware and the like.
- the computer 202 is a general purpose computer.
- the computer 202 can be an embedded computer, or a personal computer such as a laptop or desktop computer, that is capable of running the software, issuing suitable control commands, and recording information in real time.
- the computer 202 has a display 204 for reporting information to an operator of the spectroscopic system 100 , a keyboard 206 for enabling the operator to enter information and commands, and a 20 printer 208 for providing a print-out, or permanent record, of measurements made by the spectroscopic system 100 and for printing diagnostic results, for example, for inclusion in the chart of a patient.
- some commands entered at the keyboard enable a user to select a particular spectrum for analysis or to reject a spectrum, and to select particular segments of a spectrum for normalization.
- Other commands enable a user to select the wavelength range for each particular segment and to specify both wavelength contiguous and non-contiguous segments.
- the console 102 also includes an ultraviolet (UV) source 210 such as a nitrogen laser or a frequency-tripled Nd:YAG laser, a white light source 212 such as one or more Xenon flash lamps, and control electronics 214 for controlling the light sources both as to intensity and as to the time of onset of operation and the duration of operation.
- UV ultraviolet
- One or more power supplies 216 are included in the console 102 , to provide regulated power for the operation of all of the components.
- the console 102 also includes at least one spectrometer and at least one detector (spectrometer and detector 218 ) suitable for use with each of the light sources.
- a single spectrometer can operate with both the UV light source and the white light source.
- the same detector can record UV and white light signals, and in some embodiments different detectors are used for each light source.
- the console 102 also includes coupling optics 220 to couple the UV illumination from the UV light source 210 to one or more optical fibers in the cable 106 for transmission to the probe 104 , and for coupling the white light illumination from the white light source 212 to one or more optical fibers in the cable 106 for transmission to the probe 104 .
- the console 102 also includes coupling optics 222 to couple the spectral response of a specimen to UV illumination from the UV light source 210 observed by the probe 104 and carried by one or more optical fibers in the cable 106 for transmission to the spectrometer and detector 218 , and for coupling the spectral response of a specimen to the white light illumination from the white light source 212 observed by the probe 104 and carried by one or more optical fibers in the cable 106 for transmission to the spectrometer and detector 218 .
- the console 102 includes a footswitch 224 to enable an operator of the spectroscopic system 100 to signal when it is appropriate to commence a spectral observation by stepping on the switch. In this manner, the operator has his or her hands free to perform other tasks, for example, aligning the probe 104 .
- the console 102 includes a calibration port 226 for calibrating the optical components of the spectrometer system.
- the operator places the probe 104 in registry with the calibration port 226 and issues a command that starts the calibration operation.
- a calibrated light source provides illumination of known intensity as a function of wavelength as a calibration signal.
- the probe 104 detects the calibration signal.
- the probe 104 transmits the detected signal through the optical fiber in the cable 106 , through the coupling optics 222 to the spectrometer and detector 218 .
- a test spectral result is obtained.
- a calibration of the spectral system is computed as the ratio of the amplitude of the known illumination at a particular wavelength divided by the test spectral result at the same wavelength.
- the probe 104 includes probe optics 230 for illuminating a specimen to be analyzed with UV and white light from the UV source 210 and the white light source 212 , and for collecting the fluorescent and backscatter (or reflectance) illumination from the specimen that is being analyzed.
- the probe includes a scanner assembly 232 that provides illumination from the UV source 210 in a raster pattern over a target area of the specimen of cervical tissue to be analyzed.
- the probe includes a video camera 234 for observing and recording visual images of the specimen under analysis.
- the probe 104 includes a targeting souce 236 , which can be used to determine where on the surface of the specimen to be analyzed the probe 104 is pointing.
- the probe 104 also includes a white light illuminator 238 to assist the operator in visualizing the specimen to be analyzed.
- the computer 202 controls the actions of the light sources 210 , 212 , the coupling optics 220 , the transmission of light signals and electrical signals through the cable 106 , the operation of the probe optics 230 and the scanner assembly 232 , the retreival of observed spectra via the cable 106 , the coupling of the observed spectra via the coupling optics 222 into the spectrometer and detector 218 , the operation of the spectrometer and detector 218 , and the subsequent signal procesing and analysis of the recorded spectra.
- FIG. 3 is a detailed schematic flow diagram 300 showing exemplary steps of combining the fluorescence spectrum analysis described more fully in FIG. 6 below with the reflectance spectrum analysis described more fully in FIG. 7 below to perform tissue characterization according to an illustrative embodiment of the invention.
- Step 310 indicates that the results presented in FIG. 6 for analysis of fluorescence spectra from a test specimen of unknown condition or unknown state of health are available.
- the computer 202 determines whether the test specimen can be classified as “normal,” or “metaplasia,” or can not be classified by fluorescence spectroscopy alone. This process is described in detail at step 665 of FIG. 6 below.
- a decision is taken as to whether the test specimen has a definitive state of health, for example that the specimen is “normal.” If the test specimen can be classified, for example as normal, the method ends at step 330 .
- the computer 202 further analyses information available from a reflectance spectrum or from a plurality of reflectance spectra taken from the test specimen.
- the computer 202 provides reflectance spectra processed according to the systems and methods described in connection with FIG. 7 below.
- a mean normalization step is performed by computer 202 , as indicated at step 340 .
- This mean normalization step is described in detail at step 755 of FIG. 7 below.
- the mean normalization is carried out using a plurality of reflectance spectra taken from specimens that are known to represent normal squamous tissue. In one embodiment, a single test specimen is examined at multiple locations, each location measuring approximately one millimeter in diameter. If one or more locations of the test specimen provide fluorescence spectra that indicate that those locations can be classified as representing normal squamous tissue, using the methods and systems described in FIG. 6 below, the reflectance spectra recorded from those locations are used to mean normalize the reflectance spectra obtained from locations that are not capable of being classified as “normal” or “metaplasia” solely on the basis of fluorescence spectra.
- the computer 202 can carry out an analysis using a metric as described in detail at FIG. 7, step 760 below, for example using the Mahalanobis distance as a metric in N-dimensional space.
- the test reflectance spectra are truncated to the wavelength regions 391 nm to 484 nm, and 532 nm to 625 nm.
- the classifications CIN I and CIN II/II are the classifications that are possible for a test spectrum that is neither classified as “normal” nor “metaplasia” by fluorescence spectral analysis.
- the computer 202 classifies the test specimen as having a condition or state of health selected from CIN I and CIN II/III based on the value of the metric computed by the computer 202 , provided that the value of the metric does not exceed a pre-determined maximum value.
- the computer 202 presents the results of the classification of the test specimen, as a condition or state of health corresponding to one of normal, metaplasia, CIN I and CIN II/III.
- FIG. 4 is a diagram 400 showing an exemplary fluorescence spectrum recorded using the spectroscopic system of FIG. 1.
- a curve 410 having an amplitude defined in terms of number of counts, for example a signal strength expressed as numbers of photons, as indicated along the vertical axis 420 .
- An amplitude is plotted against a wavelength of light expressed in nm, as indicated along the horizontal axis 430 .
- Such spectra can be recorded using the methods and systems described in FIGS. 1 - 3 with an illumination source that provides optical excitation comprising a substantially monochromatic source in the ultraviolet portion of the optical spectrum.
- the exemplary fluorescence spectrum depicted in FIG. 4 was recorded from human cervical tissue using ultraviolet illumination.
- FIG. 5 is a diagram 500 showing an exemplary reflectance spectrum recorded using the spectroscopic system of FIG. 1.
- a curve 510 having an amplitude defined in terms of number of counts, for example a signal strength expressed as numbers of photons, as indicated along the vertical axis 520 .
- An amplitude is plotted against a wavelength of light expressed in nm, as indicated along the horizontal axis 530 .
- Such spectra can be recorded using the methods and systems described in FIGS. 1 - 3 with an illumination source that provides optical excitation comprising a broadband source in the visible portion of the optical spectrum.
- the exemplary reflectance spectrum depicted in FIG. 5 was recorded from human cervical tissue using broadband visible light illumination.
- FIG. 6 is a schematic flow diagram 600 depicting an analysis of a fluorescence spectrum in a system according to an illustrative embodiment of the invention.
- Fluorescence spectra such as the exemplary spectrum of FIG. 4 are suitable for the analysis described hereafter.
- the spectral analysis involves the measurement of spectra from a test specimen whose condition is to be determined, and employs a plurality of reference spectra taken from one or more specimens having known conditions.
- the reference spectra can be obtained before, after, or at the same operation session as the test spectrum or spectra are obtained.
- the treatment of the reference spectra will be described first. The treatment of a test spectrum will then be described.
- the term “characteristic N-dimensional value” should be understood to comprehend whichever of a point, a volume, a surface, a probability distribution or the like is used in the subsequent analysis.
- the “characteristic N-dimensional value” can be understood to be an ordered N-tuple of values, each one of which values can be expressed in its own dimensional units. It is well known in the spectroscopic arts to record one or more reference spectra from specimens that are known to have specific conditions. For example, it is known to record reference spectra from specimens having known states of health or known disease conditions. Reference spectra can be manipulated using the same pre-processing methods that are applied to spectra recorded from test specimens, so as to be able to compare spectra having substantially similar processing histories.
- the computer 202 can store in a machine-readable memory for later use the information comprising the various characteristic N-dimensional values that are computed, as well as the corresponding known condition.
- the computer 202 can also similarly store in a machine-readable memory the various reference reflectance spectra data that were obtained.
- an operator collects and records a test fluorescence spectrum or a plurality of test fluorescence spectra from a test specimen of unknown state of health or unknown condition.
- Step 615 indicates that the computer 202 can smooth the raw data.
- Various mathematical smoothing techniques are known in the art, such as computing moving averages, or applying filters to remove noise, for example using well-known convolution methods.
- Step 620 indicates that the computer 202 can subtract a background reading, for example a reading taken using the systems and methods of FIGS. 1 - 3 with a standard specimen, or taken without a test specimen, from the reading observed from a test specimen or a reference specimen.
- the computer 202 can average a plurality of spectral data taken from the same specimen, for example, the computer 202 can average N repeated spectral measurements taken from the same location of a single specimen, where N is an integer greater than 1.
- the computer 202 can correct the wavelength assigned to a particular amplitude of a spectrum, or can correct a plurality of such wavelengths.
- the computer 202 can perform such a correction by using a pre-recorded calibration file recorded from an optical source having lines at known wavelengths, for example a spectrum recorded from a lamp having the characteristic emission lines of mercury, or another well known emission source.
- the computer 202 uses the known wavelengths of the characteristic emission lines to determine a relationship between wavelength and a data channel number assigned by the computer 202 and an A/D converter to the characteristic spectra.
- the computer 202 can determine a wavelength for each A/D channel and thus knows the correct wavelength to assign to each amplitude.
- the computer 202 can correct the spectral data for effects ascribable to open air, such as absorption due to atmospheric constituents, for example gases such as water vapor, carbon dioxide, and others that have strong absorption at characteristic wavelengths.
- Step 640 indicates that the computer 202 can correct for instrument-induced features by dividing an observed spectrum by an instrument function.
- the instrument function is obtained by dividing a known, accurate spectrum, such as a NIST-traceable tungsten lamp spectrum, by the observed spectrum recorded for illumination from such a lamp passing through the instrument of FIGS. 1 and 2.
- Dividing a first spectrum by a second spectrum involves dividing the respective amplitudes of the first spectrum by the corresponding amplitudes for the second spectrum and recording the result of each such division in a file as a function of the respective wavelengths, such as the instrument function.
- Step 645 indicates that the computer 202 can truncate a spectrum to limit the data saved to a file as amplitudes corresponding to the reduced set of wavelengths, rather than all the wavelengths that the spectral instrument of FIGS. 1 - 2 is capable of recording.
- the truncation is performed to avoid saving data that has no significance, such as data corresponding to amplitudes having zero intensity for wavelengths beyond some predetermined value.
- the operator can use the keyboard 206 , or another input mechanism, to indicate one or both wavelength limits of the truncated wavelength range to be retained.
- the computer 202 can reduce the number of amplitudes, each amplitude corresponding to a selected wavelength, that are used to characterize a spectrum.
- the number of amplitudes used to characterize a spectrum is fifty (50).
- as few as three amplitudes at three wavelengths may be sufficient to characterize a fluorescence spectrum as representing a test specimen comprising healthy normal squamous cells as distinguished from other tissue types having other states of health.
- the computer 202 can normalize the reduced spectral data using a system and method called normalization using non-uniform segmentation. Normalization using non-uniform segment normalization is described in detail in the co-pending patent application entitled “System for Normalizing Spectra,” which application is commonly assigned to the assignee of the present application, and which application is incorporated herein by reference in its entirety.
- the computer 202 performs a mathematical procedure intended to guarantee that a matrix used in further analytical steps is capable of being inverted.
- Matrix inversion is a mathematical process well known in the matrix mathematical arts.
- the matrix that is computed is called a Friedman matrix.
- the data used in the calculation of the Friedman matrix is obtained from reference data recorded and stored in machine-readable format. The step of computing the appropriate Friedman matrix can be performed at any time after the reference spectral data is available.
- the Friedman matrix is the weighted linear combination of a within-group covariance matrix C j and the pooled within-group covariance C that is a function of the Friedman parameters ⁇ and ⁇ . These parameters are selected from the unit interval [ 0 , 1 ]. It is important to note that the Friedman parameters are not physical quantities whose values carry classification information. Rather, they are used to insure that the weighting (Friedman) matrix is non-singular. Equation 1 details the p-by-p Friedman matrix, which is denoted by ′ ⁇ .
- ⁇ j ⁇ ( ⁇ , ⁇ ) ( 1 - ⁇ ) ⁇ [ ( 1 - ⁇ ) ⁇ C J + ⁇ ⁇ C ] + ⁇ p ⁇ tr ⁇ [ ( 1 - ⁇ ) ⁇ C j + ⁇ ⁇ C ] ⁇ I pxp Eqn . ⁇ 1
- N note that tr(A) is the trace of the matrix A, namely the sum of the diagonal elements.
- I pxp is the p-dimensional identity matrix.
- I pxp [ 1 0 ⁇ 0 0 1 ⁇ 0 ⁇ ⁇ ⁇ 0 0 ⁇ 1 pxp Eqn . ⁇ 3
- s( ⁇ p ) be a p-dimensional spectrum.
- the Mahalanobis distance d from s( ⁇ p ) to the group mean ⁇ j with respect to the associated Friedman matrix ′ ⁇ j ( ⁇ , ⁇ ) and Friedman parameters ⁇ and ⁇ is given in equation 4 below.
- d ⁇ ( s ⁇ ( ⁇ p ) , ⁇ j ) ⁇ ( s ⁇ ( ⁇ p ) - ⁇ j ) ⁇ ⁇ j ⁇ ( ⁇ , ⁇ ) - 1 ⁇ ( s ⁇ ( ⁇ p ) - ⁇ j ) T Eqn . ⁇ 4
- step 670 can be replaced by the appropriate computation.
- the computer 202 computes a metric from each test spectrum (or from an average value representing a plurality of spectra, such as performed at step 625 ) to each characteristic N-dimensional value for the reference spectra recorded.
- the metric can be a Mahalanobis distance, as indicated above.
- the metric can be the square root of the sum of the squares of the differences in coordinates in the N-dimensional space, or the metric can be the Bhattacharyya distance.
- the computer 202 examines the results obtained in step 660 , and determines a classification for the test specimen, based on the metrics computed with respect to the test fluorescence spectrum and a classification rule or relation.
- the classification relation is that the condition of the test specimen is assigned as the condition corresponding to the reference spectrum constellation or set having the Mahalanobis shortest distance, provided that the shortest Mahalanobis distance is less than a pre-determined minimum distance. In one embodiment, if no Mahalanobis distance is less than a pre-determined minimum distance, the test spectrum is discarded as being incapable of being classified, or indeterminate.
- the test fluorescence spectrum can be compared to multiple sets of reference spectra in a single comparison.
- the computations can be repeated for different sets of reference conditions. For example, a test fluorescence spectrum from a test specimen can be compared in a first computation to reference fluorescence spectral data for normal squamous tissue and CIN II/III tissue, compared in a second computation to reference fluorescence spectral data for normal squamous tissue and CIN I tissue, and compared in a third computation to reference fluorescence spectral data for normal squamous tissue and metaplasia tissue.
- test fluorescence spectrum is classified in each of the three comparisons as being more closely related to the reference spectra for normal squamous tissue, the test specimen can be classified by the computer 202 as having normal health, and the classification process is complete. However, if the test fluorescence spectrum is classified in either of the comparisons involving CIN I or CIN II/III as being less closely related to the reference spectra for normal squamous tissue than one of the other conditions or states of health (namely CIN I, or CIN II/III), the computer 202 can report that the state of health of the test specimen is not clearly that of normal squamous tissue, and that further analysis is in order. In one embodiment, the further analysis involves the recording and examination of reflectance spectra.
- FIG. 7 is a schematic flow diagram 700 depicting an analysis of a reflectance spectrum in a system according to an illustrative embodiment of the invention.
- Reflectance spectra such as the exemplary spectrum of FIG. 5 are suitable for the analysis described hereafter.
- the spectral analysis involves the measurement of spectra from a test specimen whose condition is to be determined, and employs a plurality of reference spectra taken from one or more specimens having known conditions. Those of ordinary skill in the spectroscopic arts will understand that the reference spectra can be obtained before, after, or at the same operation session as the test spectrum or spectra are obtained.
- the computer 202 can store in a machine-readable memory for later use the information comprising the various characteristic N-dimensional values that are computed, as well as the corresponding known condition.
- the computer 202 can also similarly store in a machine-readable memory the various reference reflectance spectra data that were obtained.
- an operator collects and records a test reflectance spectrum or a plurality of test reflectance spectra from a test specimen of unknown state of health or unknown condition.
- Step 715 indicates that the computer 202 can smooth the raw data.
- Various mathematical smoothing techniques are known in the art, such as computing moving averages, or applying filters to remove noise, for example using well-known convolution methods.
- Step 720 indicates that the computer 202 can subtract a background reading, for example a reading taken using the systems and methods of FIGS. 1 - 3 with a standard specimen, or taken without a test specimen, from the reading observed from a test specimen or a reference specimen.
- the computer 202 can average a plurality of spectral data taken from the same specimen, for example, the computer 202 can average N repeated spectral measurements taken from the same location of a single specimen, where N is an integer greater than 1.
- the computer 202 can correct the wavelength assigned to a particular amplitude of a spectrum, or can correct a plurality of such wavelengths.
- the computer 202 can perform such a correction by using a pre-recorded calibration file recorded from an optical source having lines at known wavelengths, for example a spectrum recorded from a lamp having the characteristic emission lines of mercury, or another well known emission source.
- the computer 202 uses the known wavelengths of the characteristic emission lines to determine a relationship between wavelength and a data channel number assigned by the computer 202 and an A/D converter to the characteristic spectra.
- the computer 202 can determine a wavelength for each A/D channel and thus knows the correct wavelength to assign to each amplitude.
- the computer 202 can correct the spectral data for effects ascribable to open air, such as absorption due to atmospheric constituents, for example gases such as water vapor, carbon dioxide, and others that have strong absorption at characteristic wavelengths.
- Step 740 indicates that the computer 202 can correct for instrument-induced features by dividing an observed spectrum by an instrument function.
- the instrument function is obtained by dividing a known, accurate spectrum, such as a NIST-raceable tungsten lamp spectrum, by the observed spectrum recorded for illumination from such a lamp passing through the instrument of FIGS. 1 and 2.
- Dividing a first spectrum by a second spectrum involves dividing the respective amplitudes of the first spectrum by the corresponding amplitudes for the second spectrum and recording the result of each such division in a file as a function of the respective wavelengths, such as the instrument function.
- Step 745 indicates that the computer 202 can truncate a spectrum to limit the data saved to a file as amplitudes corresponding to the reduced set of wavelengths, rather than all the wavelengths that the spectral instrument of FIGS. 1 - 2 is capable of recording.
- the truncation is performed to avoid saving data that has no significance, such as data corresponding to amplitudes having zero intensity for wavelengths beyond some predetermined value.
- the operator can use the keyboard 206 , or another input mechanism, to indicate one or both wavelength limits of the truncated wavelength range to be retained.
- the computer 202 can reduce the number of amplitudes, each amplitude corresponding to a selected wavelength, that are used to characterize a spectrum.
- the number of amplitudes used to characterize a spectrum is fifty ( 50 ).
- as few as three amplitudes at three wavelengths may be sufficient to characterize a reflectance spectrum as representing a test specimen comprising healthy normal squamous cells as distinguished from other tissue types having other states of health.
- the computer 202 can normalize the reduced spectral data using a system and method called mean normalization.
- Mean normalization involves determining a mean value at each wavelength of interest for reference reflectance spectra and subtracting the mean values so determined at a particular wavelength of interest from the amplitude of the test spectrum (or spectra) at the same wavelength.
- the computer 202 performs a mathematical procedure intended to guarantee that a matrix used in further analytical steps is capable of being inverted.
- Matrix inversion is a mathematical process well known in the matrix mathematical arts.
- the matrix that is computed is called a Friedman matrix.
- the data used in the calculation of the Friedman matrix is obtained from the stored data recorded in machine-readable format.
- the step of computing the appropriate Friedman matrix can be performed at any time after the reference spectral data is available.
- the Friedman matrix is the weighted linear combination of a within-group covariance matrix C j and the pooled within-group covariance C that is a function of the Friedman parameters ⁇ and ⁇ . These parameters are selected from the unit interval [0,1]. It is important to note that the Friedman parameters are not physical quantities whose values carry classification information. Rather, they are used to insure that the weighting (Friedman) matrix is non-singular. Equation 5 details the p-by-p Friedman matrix, which is denoted by ′ ⁇ .
- ⁇ j ⁇ ( ⁇ , ⁇ ) ( 1 - ⁇ ) ⁇ [ ( 1 - ⁇ ) ⁇ C j + ⁇ ⁇ C ] + ⁇ p ⁇ tr ⁇ [ ( 1 - ⁇ ) ⁇ C j + ⁇ ⁇ C ] ⁇ I pxp Eqn . ⁇ 5
- tr(A) is the trace of the matrix A, namely the sum of the diagonal elements.
- I pxp is the p-dimensional identity matrix.
- I pxp [ 1 0 ⁇ 0 0 1 ⁇ 0 ⁇ ⁇ ⁇ ⁇ 0 0 ⁇ 1 pxp Eqn . ⁇ 7
- s( ⁇ p ) be a p-dimensional spectrum.
- the Mahalanobis distance d from s(Ap) to the group mean ⁇ j with respect to the associated Friedman matrix ′ ⁇ ( ⁇ , ⁇ ) and Friedman parameters ⁇ and ⁇ is given in equation 8 below.
- d ⁇ ( s ⁇ ( ⁇ p ) , ⁇ j ) ⁇ ( s ⁇ ( ⁇ p ) - ⁇ j ) ⁇ ⁇ j ⁇ ( ⁇ , ⁇ ) - 1 ⁇ ( s ⁇ ( ⁇ p ) - ⁇ j ) T ⁇ Eqn . ⁇ 8
- step 770 can be replaced by the appropriate computation.
- the computer 202 computes a metric from each test spectrum (or from an average value representing a plurality of spectra, such as performed at step 725 ) to each characteristic N-dimensional value for the reference spectra recorded.
- the metric can be a Mahalanobis distance, as indicated above.
- the metric can be the square root of the sum of the squares of the differences in coordinates in the N-dimensional space, or the metric can be the Bhattacharyya distance.
- the computer 202 examines the results obtained in step 760 , and determines a classification for the test specimen, based on the metrics computed with respect to the test reflectance spectrum and a classification rule or relation.
- the classification relation is that the condition of the test specimen is assigned as the condition corresponding to the reference spectrum constellation or set having the Mahalanobis shortest distance, provided that the shortest Mahalanobis distance is less than a pre-determined minimum distance. In one embodiment, if no Mahalanobis distance is less than a pre-determined minimum distance, the test spectrum is discarded as being incapable of being classified, or indeterminate.
- the test reflectance spectrum can be compared to multiple sets of reference spectra in a single comparison.
- the computations can be repeated for different sets of reference conditions. For example, a test reflectance spectrum from a test specimen can be compared in a first computation to reference reflectance spectral data for normal squamous tissue and CIN II/III tissue, compared in a second computation to reference reflectance spectral data for normal squamous tissue and CIN I tissue, and compared in a third computation to reference reflectance spectral data for normal squamous tissue and metaplasia tissue.
- test reflectance spectrum is classified in each of the three comparisons as being more closely related to the reference spectra for normal squamous tissue, the test specimen can be classified by the computer 202 as having normal health, and the classification process is complete. However, if the test reflectance spectrum is classified in either of the comparisons involving CIN I or CIN II/III as being less closely related to the reference spectra for normal squamous tissue than one of the other conditions or states of health (namely CIN I, or CIN II/III), the computer 202 can report that the state of health of the test specimen is not clearly that of normal squamous tissue, and that further analysis is in order. In one embodiment, the further analysis involves the recording and examination of reflectance spectra.
Abstract
Description
- This application is a continuation-in-part of U.S. patent application Ser. No. 09/470,071, filed Dec. 22, 1999, which claims priority to and the benefit of U.S. provisional patent application Ser. No. 60/113,761, filed Dec. 23, 1998, and this application is related to the U.S. patent application entitled, “System for Normalizing Spectra” and identified by Attorney Docket Number MDS-020, filed on even date herewith, and to the U.S. patent application entitled, “Spectral Data Classification Of Samples” and identified by Attorney Docket Number MDS-021, filed on even date herewith. All of the above applications are assigned to the common assignee of this application, and are hereby incorporated by reference.
- [0002] This invention was made with government support under Contract No. CA 66481awarded by National Cancer Institute, NIH. The government may have certain rights in the invention.
- This invention relates generally to spectroscopic systems. More particularly, in one embodiment, the invention relates to a spectroscopic system for characterizing test specimens using a plurality of spectral data types.
- Spectral analysis of biological specimens has been used for disease diagnosis. In general, spectra are recorded as values of amplitude, typically measured as a response to an excitation, as a function of wavelength (or the inverse of wavelength, namely frequency). In the field of spectral analysis, different kinds of information are conveyed by different spectral types. For example, fluorescence spectra are recorded using a source of excitation illumination that is absorbed by a specimen and that causes the specimen to emit a fluorescence spectrum that depends in part on the transfer of energy within and among atoms and/or molecules in the specimen. An illumination source for use in observing and recording fluorescence spectra generally operates at a selected monochromatic wavelength, or a narrow range of wavelengths. Different sources of illumination that operate at different wavelengths can excite different constituents of a specimen. In addition, different sources of illumination that operate at different wavelengths can excite the same constituent with different efficiencies. Thus, a fluorescence spectrum can depend on both the excitation wavelength that is used to illuminate a specimen and on the composition of the specimen itself. Other effects also play a role in determining a fluorescence spectrum, for example, instrumental effects, effects relating to polarization of the illumination, or thermal effects.
- Some progress has been made in using various optical spectral methods for analysis of test specimens, including biological specimens. However, the wide variety of physical and chemical influences present in a test specimen that play roles in determining an observed spectrum make difficult both the choice of a suitable illumination source, and the interpretation of the resulting spectrum. This is in part true because there are so many influences on the kind and amount of information that an optical spectrum conveys that it is hard to find clear cause and effect relationships among the multitude of competing influences.
- The invention provides methods of determining the disease state of a biological specimen based upon a reflectance spectrum residual derived by subtracting from a reflectance spectrum obtained from a test specimen an average reflectance spectrum obtained from a plurality if healthy specimens. In a preferred embodiment, members of the plurality of healthy specimens are determined to be healthy based upon the fluorescence spectra emitted by those samples. Typically, the specimen to be tested exhibits a fluorescence spectrum that is not characteristic of healthy tissue. The reflectance spectrum residual provides a criterion for diagnostic classification of a specimen that is judged to be indeterminate in classification by its fluorescence spectrum alone. Accordingly, methods of the invention resolve diagnostic ambiguities created when a specimen produces a fluorescence spectrum that is not characteristic of a healthy tissue. Similarly, methods of the invention are also useful to resolve diagnostic ambiguities created when the fluorescence spectrum of a test specimen is not characteristic of any known disease state.
- In one aspect, the invention provides a method of determining a condition of a test specimen. The method comprises recording both fluorescence and reflectance spectra from specific specimen. The method then comprises identifying a plurality of specimens having a fluorescence spectrum characteristic of a known condition; obtaining an average reflectance spectrum based upon the plurality of first test specimens; obtaining a reflectance spectrum from a test specimen that produces a fluorescence spectrum that is not characteristic of the known condition; and obtaining a reflectance spectrum residual by subtracting the average reflectance spectrum from the reflectance spectrum obtained from the test specimen. Determination of the condition of the test specimen is based upon the reflectance spectrum residual. In a preferred embodiment, the condition of the test specimen is based upon an amplitude of one or more features of the reflectance spectrum residual. For purposes of the invention a “condition” is a state of disease, including a healthy state or simply the physiological makeup of the specimen and/or the patient from whom it was obtained.
- In one embodiment, the plurality of specimens producing the average reflectance spectrum comprises tissue specimens and the test specimen is a tissue specimen of the same type. In one embodiment, the tissue specimens are human cervical tissue specimens, the condition of which is healthy, and the condition of the test specimen is determined by methods of the invention. In one embodiment, cervical tissue producing the average reflectance spectrum are selected from normal squamous tissue, metaplasia, mile cervical intraepithelial neoplasia (CIN I), and moderate to severe cervical intraepithelial neoplasia (CIN II/III). In another embodiment, methods of the invention further comprise obtaining additional optical information from the test specimen, and evaluating the additional optical information in comparison to the fluorescence spectrum and the reflectance spectrum from the test specimen to determine the condition of the test specimen. In one embodiment, the additional optical information is video information. In another embodiment, the additional optical information is an optical image.
- In one aspect, the invention relates to a spectroscopic system for determining a condition of a test specimen. The system comprises a data collection module that collects a fluorescence spectrum characteristic of a known condition from each of a plurality of first specimens, observes a reflectance spectrum from each member of the plurality, and observes a reflectance spectrum from a test specimen that is observed to produce a second fluorescence spectrum that is not characteristic of the known condition. The system further comprises a computation module that computes an average reflectance spectrum based upon each member of the plurality of first specimens, and that computes a reflectance spectrum residual by subtracting the average reflectance spectrum from the reflectance spectrum obtained from a test specimen, and an analysis module that determines the condition of the test specimen based at least in part upon the reflectance spectrum residual.
- The foregoing and other objects, aspects, features, and advantages of the invention will become more apparent from the following description and from the claims.
- The objects and features of the invention can be better understood with reference to the drawings described below, and the claims. The drawings are not necessarily to scale, emphasis instead generally being placed upon illustrating the principles of the invention. In the drawings, like numerals are used to indicate like parts throughout the various views.
- FIG. 1 shows an exemplary spectroscopic system that employs a plurality of spectral types according to an illustrative embodiment of the invention;
- FIG. 2 shows an exemplary operational block diagram of the spectroscopic system of FIG. 1;
- FIG. 3 is a detailed schematic flow diagram showing exemplary steps of combining a fluorescence spectrum analysis described more fully in FIG. 6 with a reflectance spectrum analysis described more fully in FIG. 7 to perform tissue characterization according to an illustrative embodiment of the invention;
- FIG. 4 is a diagram showing an exemplary fluorescence spectrum recorded using the spectroscopic system of FIG. 1;
- FIG. 5 is a diagram showing an exemplary reflectance spectrum recorded using the spectroscopic system of FIG. 1;
- FIG. 6 is a schematic flow diagram depicting an analysis of a fluorescence spectrum in a system according to an illustrative embodiment of the invention; and
- FIG. 7 is a schematic flow diagram depicting an analysis of a reflectance spectrum in a system according to an illustrative embodiment of the invention.
- The invention relates to the use of multiple types of spectral data for determining the status of a test specimen. In the present invention, a first spectral observation is used to distinguish between a first condition and a plurality of other conditions, and a second observation using information obtained from a different type of spectral data is used to distinguish among the plurality of other conditions. The invention will be described in terms of embodiments that relate to the use of multiple optical spectra in characterization systems and methods, particularly in the area of medical diagnostics, and especially as such use relates to the analysis of spectra obtained from human cervical tissue in the detection of cervical cancer. However, the invention has applicability generally in the area of characterization of test specimens based on analysis of a plurality of optical spectra types.
- FIG. 1 depicts an exemplary
spectroscopic system 100 employing a plurality of spectral data types in methods and systems according to an illustrative embodiment of the invention. The spectroscopic system includes aconsole 102 connected to aprobe 104 by acable 106. Thecable 106 carries electrical and optical signals between theconsole 102 and theprobe 104. Theprobe 104 accommodates adisposable component 108 which used only once, and discarded after such use. Theconsole 102 and theprobe 104 are mechanically connected by an articulating arm 11 0, which can also support thecable 106. Theconsole 102 contains much of the hardware and the software of the system, and theprobe 104 contains the necessary hardware for making suitable spectroscopic observations. The details of the system are further explained in conjunction with FIG. 2. - FIG. 2 shows an exemplary operational block diagram200 of a spectroscopic system of the type depicted in FIG. 1. According to an illustrative embodiment, the spectroscopic system of FIGS. 1 and 2 is subtantially the same as single-beam spectrometer devices, but is adapted to include the features of the invention. The
console 102 includes acomputer 202 which executes 5 software that controls the operation of thespectroscopic system 100. The software includes one or more modules recorded on machine-readable media, which can be any medium such as magnetic disks, magnetic tape, CD-ROM, semiconductor memory, or the like. Preferably, the machine-readable medium is resident within thecomputer 202. In alternative embodiments, the machine-readable medium can be connected to thecomputer 202 by a communication link. In 10 alternative embodiments, one can substitute computer insructions in the form of hardwired logic for software, or one can substitute firmware (i.e., computer instructions recorded on devices such as PROMs, EPROMS oe EEPROMs, or the like) for software. The term machine-readable instructions as used herein is intended to encompass software, hardwired logic, firmware and the like. - The
computer 202 is a general purpose computer. Thecomputer 202 can be an embedded computer, or a personal computer such as a laptop or desktop computer, that is capable of running the software, issuing suitable control commands, and recording information in real time. Thecomputer 202 has adisplay 204 for reporting information to an operator of thespectroscopic system 100, akeyboard 206 for enabling the operator to enter information and commands, and a 20printer 208 for providing a print-out, or permanent record, of measurements made by thespectroscopic system 100 and for printing diagnostic results, for example, for inclusion in the chart of a patient. As described below in more detail, in an illustrative embodiment of the invention, some commands entered at the keyboard, enable a user to select a particular spectrum for analysis or to reject a spectrum, and to select particular segments of a spectrum for normalization. Other commands enable a user to select the wavelength range for each particular segment and to specify both wavelength contiguous and non-contiguous segments. - The
console 102 also includes an ultraviolet (UV)source 210 such as a nitrogen laser or a frequency-tripled Nd:YAG laser, awhite light source 212 such as one or more Xenon flash lamps, and controlelectronics 214 for controlling the light sources both as to intensity and as to the time of onset of operation and the duration of operation. One ormore power supplies 216 are included in theconsole 102, to provide regulated power for the operation of all of the components. Theconsole 102 also includes at least one spectrometer and at least one detector (spectrometer and detector 218) suitable for use with each of the light sources. In some embodiments, a single spectrometer can operate with both the UV light source and the white light source. In some embodiments, the same detector can record UV and white light signals, and in some embodiments different detectors are used for each light source. - The
console 102 also includescoupling optics 220 to couple the UV illumination from the UVlight source 210 to one or more optical fibers in thecable 106 for transmission to theprobe 104, and for coupling the white light illumination from thewhite light source 212 to one or more optical fibers in thecable 106 for transmission to theprobe 104. Theconsole 102 also includescoupling optics 222 to couple the spectral response of a specimen to UV illumination from the UVlight source 210 observed by theprobe 104 and carried by one or more optical fibers in thecable 106 for transmission to the spectrometer anddetector 218, and for coupling the spectral response of a specimen to the white light illumination from thewhite light source 212 observed by theprobe 104 and carried by one or more optical fibers in thecable 106 for transmission to the spectrometer anddetector 218. Theconsole 102 includes afootswitch 224 to enable an operator of thespectroscopic system 100 to signal when it is appropriate to commence a spectral observation by stepping on the switch. In this manner, the operator has his or her hands free to perform other tasks, for example, aligning theprobe 104. - The
console 102 includes acalibration port 226 for calibrating the optical components of the spectrometer system. The operator places theprobe 104 in registry with thecalibration port 226 and issues a command that starts the calibration operation. In the calibration operation, a calibrated light source provides illumination of known intensity as a function of wavelength as a calibration signal. Theprobe 104 detects the calibration signal. Theprobe 104 transmits the detected signal through the optical fiber in thecable 106, through thecoupling optics 222 to the spectrometer anddetector 218. A test spectral result is obtained. A calibration of the spectral system is computed as the ratio of the amplitude of the known illumination at a particular wavelength divided by the test spectral result at the same wavelength. - The
probe 104 includesprobe optics 230 for illuminating a specimen to be analyzed with UV and white light from theUV source 210 and thewhite light source 212, and for collecting the fluorescent and backscatter (or reflectance) illumination from the specimen that is being analyzed. The probe includes ascanner assembly 232 that provides illumination from theUV source 210 in a raster pattern over a target area of the specimen of cervical tissue to be analyzed. The probe includes avideo camera 234 for observing and recording visual images of the specimen under analysis. Theprobe 104 includes a targetingsouce 236, which can be used to determine where on the surface of the specimen to be analyzed theprobe 104 is pointing. Theprobe 104 also includes awhite light illuminator 238 to assist the operator in visualizing the specimen to be analyzed. Once the operator aligns the spectroscopic system and depresses thefootswitch 224, thecomputer 202 controls the actions of thelight sources coupling optics 220, the transmission of light signals and electrical signals through thecable 106, the operation of theprobe optics 230 and thescanner assembly 232, the retreival of observed spectra via thecable 106, the coupling of the observed spectra via thecoupling optics 222 into the spectrometer anddetector 218, the operation of the spectrometer anddetector 218, and the subsequent signal procesing and analysis of the recorded spectra. - FIG. 3 is a detailed schematic flow diagram300 showing exemplary steps of combining the fluorescence spectrum analysis described more fully in FIG. 6 below with the reflectance spectrum analysis described more fully in FIG. 7 below to perform tissue characterization according to an illustrative embodiment of the invention. Step 310 indicates that the results presented in FIG. 6 for analysis of fluorescence spectra from a test specimen of unknown condition or unknown state of health are available. At
step 320, thecomputer 202 determines whether the test specimen can be classified as “normal,” or “metaplasia,” or can not be classified by fluorescence spectroscopy alone. This process is described in detail atstep 665 of FIG. 6 below. As indicated instep 325, a decision is taken as to whether the test specimen has a definitive state of health, for example that the specimen is “normal.” If the test specimen can be classified, for example as normal, the method ends atstep 330. - In the event that a definitive condition or state of health cannot be ascribed to a test specimen, the
computer 202 further analyses information available from a reflectance spectrum or from a plurality of reflectance spectra taken from the test specimen. Atstep 335, thecomputer 202 provides reflectance spectra processed according to the systems and methods described in connection with FIG. 7 below. - If the specimen cannot be classified, a mean normalization step is performed by
computer 202, as indicated atstep 340. This mean normalization step is described in detail atstep 755 of FIG. 7 below. The mean normalization is carried out using a plurality of reflectance spectra taken from specimens that are known to represent normal squamous tissue. In one embodiment, a single test specimen is examined at multiple locations, each location measuring approximately one millimeter in diameter. If one or more locations of the test specimen provide fluorescence spectra that indicate that those locations can be classified as representing normal squamous tissue, using the methods and systems described in FIG. 6 below, the reflectance spectra recorded from those locations are used to mean normalize the reflectance spectra obtained from locations that are not capable of being classified as “normal” or “metaplasia” solely on the basis of fluorescence spectra. - As indicated in
step 350, thecomputer 202 can carry out an analysis using a metric as described in detail at FIG. 7, step 760 below, for example using the Mahalanobis distance as a metric in N-dimensional space. In one embodiment, the test reflectance spectra are truncated to the wavelength regions 391 nm to 484 nm, and 532 nm to 625 nm. In one embodiment, the classifications CIN I and CIN II/II are the classifications that are possible for a test spectrum that is neither classified as “normal” nor “metaplasia” by fluorescence spectral analysis. As indicated atstep 350, thecomputer 202 classifies the test specimen as having a condition or state of health selected from CIN I and CIN II/III based on the value of the metric computed by thecomputer 202, provided that the value of the metric does not exceed a pre-determined maximum value. - At
step 360, thecomputer 202 presents the results of the classification of the test specimen, as a condition or state of health corresponding to one of normal, metaplasia, CIN I and CIN II/III. - FIG. 4 is a diagram400 showing an exemplary fluorescence spectrum recorded using the spectroscopic system of FIG. 1. In FIG. 4, a
curve 410 having an amplitude defined in terms of number of counts, for example a signal strength expressed as numbers of photons, as indicated along thevertical axis 420. An amplitude is plotted against a wavelength of light expressed in nm, as indicated along thehorizontal axis 430. Such spectra can be recorded using the methods and systems described in FIGS. 1-3 with an illumination source that provides optical excitation comprising a substantially monochromatic source in the ultraviolet portion of the optical spectrum. The exemplary fluorescence spectrum depicted in FIG. 4 was recorded from human cervical tissue using ultraviolet illumination. - FIG. 5 is a diagram500 showing an exemplary reflectance spectrum recorded using the spectroscopic system of FIG. 1. In FIG. 5, a
curve 510 having an amplitude defined in terms of number of counts, for example a signal strength expressed as numbers of photons, as indicated along thevertical axis 520. An amplitude is plotted against a wavelength of light expressed in nm, as indicated along thehorizontal axis 530. Such spectra can be recorded using the methods and systems described in FIGS. 1-3 with an illumination source that provides optical excitation comprising a broadband source in the visible portion of the optical spectrum. The exemplary reflectance spectrum depicted in FIG. 5 was recorded from human cervical tissue using broadband visible light illumination. - FIG. 6 is a schematic flow diagram600 depicting an analysis of a fluorescence spectrum in a system according to an illustrative embodiment of the invention. Fluorescence spectra such as the exemplary spectrum of FIG. 4 are suitable for the analysis described hereafter. The spectral analysis involves the measurement of spectra from a test specimen whose condition is to be determined, and employs a plurality of reference spectra taken from one or more specimens having known conditions. Those of ordinary skill in the spectroscopic arts will understand that the reference spectra can be obtained before, after, or at the same operation session as the test spectrum or spectra are obtained. For purposes of exposition, the treatment of the reference spectra will be described first. The treatment of a test spectrum will then be described.
- In the present application, the term “characteristic N-dimensional value” should be understood to comprehend whichever of a point, a volume, a surface, a probability distribution or the like is used in the subsequent analysis. In mathematical terms, the “characteristic N-dimensional value” can be understood to be an ordered N-tuple of values, each one of which values can be expressed in its own dimensional units. It is well known in the spectroscopic arts to record one or more reference spectra from specimens that are known to have specific conditions. For example, it is known to record reference spectra from specimens having known states of health or known disease conditions. Reference spectra can be manipulated using the same pre-processing methods that are applied to spectra recorded from test specimens, so as to be able to compare spectra having substantially similar processing histories.
- The
computer 202 can store in a machine-readable memory for later use the information comprising the various characteristic N-dimensional values that are computed, as well as the corresponding known condition. Thecomputer 202 can also similarly store in a machine-readable memory the various reference reflectance spectra data that were obtained. - Turning to the discussion of the recording and analysis of a test spectrum, as indicated in FIG. 6 at
step 610, an operator collects and records a test fluorescence spectrum or a plurality of test fluorescence spectra from a test specimen of unknown state of health or unknown condition. -
Step 615 indicates that thecomputer 202 can smooth the raw data. Various mathematical smoothing techniques are known in the art, such as computing moving averages, or applying filters to remove noise, for example using well-known convolution methods. -
Step 620 indicates that thecomputer 202 can subtract a background reading, for example a reading taken using the systems and methods of FIGS. 1-3 with a standard specimen, or taken without a test specimen, from the reading observed from a test specimen or a reference specimen. Instep 625, thecomputer 202 can average a plurality of spectral data taken from the same specimen, for example, thecomputer 202 can average N repeated spectral measurements taken from the same location of a single specimen, where N is an integer greater than 1. - In
step 630, thecomputer 202 can correct the wavelength assigned to a particular amplitude of a spectrum, or can correct a plurality of such wavelengths. Thecomputer 202 can perform such a correction by using a pre-recorded calibration file recorded from an optical source having lines at known wavelengths, for example a spectrum recorded from a lamp having the characteristic emission lines of mercury, or another well known emission source. Thecomputer 202 uses the known wavelengths of the characteristic emission lines to determine a relationship between wavelength and a data channel number assigned by thecomputer 202 and an A/D converter to the characteristic spectra. Thecomputer 202 can determine a wavelength for each A/D channel and thus knows the correct wavelength to assign to each amplitude. - As indicated in
step 635, thecomputer 202 can correct the spectral data for effects ascribable to open air, such as absorption due to atmospheric constituents, for example gases such as water vapor, carbon dioxide, and others that have strong absorption at characteristic wavelengths. -
Step 640 indicates that thecomputer 202 can correct for instrument-induced features by dividing an observed spectrum by an instrument function. The instrument function is obtained by dividing a known, accurate spectrum, such as a NIST-traceable tungsten lamp spectrum, by the observed spectrum recorded for illumination from such a lamp passing through the instrument of FIGS. 1 and 2. Dividing a first spectrum by a second spectrum involves dividing the respective amplitudes of the first spectrum by the corresponding amplitudes for the second spectrum and recording the result of each such division in a file as a function of the respective wavelengths, such as the instrument function. -
Step 645 indicates that thecomputer 202 can truncate a spectrum to limit the data saved to a file as amplitudes corresponding to the reduced set of wavelengths, rather than all the wavelengths that the spectral instrument of FIGS. 1-2 is capable of recording. The truncation is performed to avoid saving data that has no significance, such as data corresponding to amplitudes having zero intensity for wavelengths beyond some predetermined value. In some embodiments, the operator can use thekeyboard 206, or another input mechanism, to indicate one or both wavelength limits of the truncated wavelength range to be retained. - As indicated at
step 650, thecomputer 202 can reduce the number of amplitudes, each amplitude corresponding to a selected wavelength, that are used to characterize a spectrum. In some embodiments, the number of amplitudes used to characterize a spectrum is fifty (50). In principle, as few as three amplitudes at three wavelengths may be sufficient to characterize a fluorescence spectrum as representing a test specimen comprising healthy normal squamous cells as distinguished from other tissue types having other states of health. - As indicated at
step 655, thecomputer 202 can normalize the reduced spectral data using a system and method called normalization using non-uniform segmentation. Normalization using non-uniform segment normalization is described in detail in the co-pending patent application entitled “System for Normalizing Spectra,” which application is commonly assigned to the assignee of the present application, and which application is incorporated herein by reference in its entirety. - In one embodiment, where the metric to be used in classifying a test specimen is a Mahalanaobis distance, the
computer 202 performs a mathematical procedure intended to guarantee that a matrix used in further analytical steps is capable of being inverted. Matrix inversion is a mathematical process well known in the matrix mathematical arts. In one embodiment, the matrix that is computed is called a Friedman matrix. The data used in the calculation of the Friedman matrix is obtained from reference data recorded and stored in machine-readable format. The step of computing the appropriate Friedman matrix can be performed at any time after the reference spectral data is available. - Computation of the Mahalanobis distance requires the inversion of a weighting matrix. One approach (i.e., Linear Discriminant Analysis) utilizes the inverse of the pooled within-groups covariance while another method (Quadratic Discriminant Analysis) employs the inverse of each within-group covariance. When a “large” number of wavelengths are used (e.g., for large p), either of the aforementioned matrices can be singular and hence cannot be inverted. Therefore, an alternate weighting matrix called the Friedman matrix is used.
- γ
-
-
-
- Where other metrics are used to classify a test spectrum and a test specimen, the step670 can be replaced by the appropriate computation.
- As indicated at
step 660, thecomputer 202 computes a metric from each test spectrum (or from an average value representing a plurality of spectra, such as performed at step 625) to each characteristic N-dimensional value for the reference spectra recorded. In one embodiment, the metric can be a Mahalanobis distance, as indicated above. In other embodiments, the metric can be the square root of the sum of the squares of the differences in coordinates in the N-dimensional space, or the metric can be the Bhattacharyya distance. - At
step 665, thecomputer 202 examines the results obtained instep 660, and determines a classification for the test specimen, based on the metrics computed with respect to the test fluorescence spectrum and a classification rule or relation. In one embodiment, the classification relation is that the condition of the test specimen is assigned as the condition corresponding to the reference spectrum constellation or set having the Mahalanobis shortest distance, provided that the shortest Mahalanobis distance is less than a pre-determined minimum distance. In one embodiment, if no Mahalanobis distance is less than a pre-determined minimum distance, the test spectrum is discarded as being incapable of being classified, or indeterminate. - In one embodiment, the test fluorescence spectrum can be compared to multiple sets of reference spectra in a single comparison. In one embodiment, the computations can be repeated for different sets of reference conditions. For example, a test fluorescence spectrum from a test specimen can be compared in a first computation to reference fluorescence spectral data for normal squamous tissue and CIN II/III tissue, compared in a second computation to reference fluorescence spectral data for normal squamous tissue and CIN I tissue, and compared in a third computation to reference fluorescence spectral data for normal squamous tissue and metaplasia tissue. If the test fluorescence spectrum is classified in each of the three comparisons as being more closely related to the reference spectra for normal squamous tissue, the test specimen can be classified by the
computer 202 as having normal health, and the classification process is complete. However, if the test fluorescence spectrum is classified in either of the comparisons involving CIN I or CIN II/III as being less closely related to the reference spectra for normal squamous tissue than one of the other conditions or states of health (namely CIN I, or CIN II/III), thecomputer 202 can report that the state of health of the test specimen is not clearly that of normal squamous tissue, and that further analysis is in order. In one embodiment, the further analysis involves the recording and examination of reflectance spectra. - FIG. 7 is a schematic flow diagram700 depicting an analysis of a reflectance spectrum in a system according to an illustrative embodiment of the invention. Reflectance spectra such as the exemplary spectrum of FIG. 5 are suitable for the analysis described hereafter. The spectral analysis involves the measurement of spectra from a test specimen whose condition is to be determined, and employs a plurality of reference spectra taken from one or more specimens having known conditions. Those of ordinary skill in the spectroscopic arts will understand that the reference spectra can be obtained before, after, or at the same operation session as the test spectrum or spectra are obtained.
- The
computer 202 can store in a machine-readable memory for later use the information comprising the various characteristic N-dimensional values that are computed, as well as the corresponding known condition. Thecomputer 202 can also similarly store in a machine-readable memory the various reference reflectance spectra data that were obtained. - Turning to the discussion of the recording an analysis of a test spectrum, as indicated in FIG. 7 at
step 710, an operator collects and records a test reflectance spectrum or a plurality of test reflectance spectra from a test specimen of unknown state of health or unknown condition. -
Step 715 indicates that thecomputer 202 can smooth the raw data. Various mathematical smoothing techniques are known in the art, such as computing moving averages, or applying filters to remove noise, for example using well-known convolution methods. -
Step 720 indicates that thecomputer 202 can subtract a background reading, for example a reading taken using the systems and methods of FIGS. 1-3 with a standard specimen, or taken without a test specimen, from the reading observed from a test specimen or a reference specimen. Instep 725, thecomputer 202 can average a plurality of spectral data taken from the same specimen, for example, thecomputer 202 can average N repeated spectral measurements taken from the same location of a single specimen, where N is an integer greater than 1. - In
step 730, thecomputer 202 can correct the wavelength assigned to a particular amplitude of a spectrum, or can correct a plurality of such wavelengths. Thecomputer 202 can perform such a correction by using a pre-recorded calibration file recorded from an optical source having lines at known wavelengths, for example a spectrum recorded from a lamp having the characteristic emission lines of mercury, or another well known emission source. Thecomputer 202 uses the known wavelengths of the characteristic emission lines to determine a relationship between wavelength and a data channel number assigned by thecomputer 202 and an A/D converter to the characteristic spectra. Thecomputer 202 can determine a wavelength for each A/D channel and thus knows the correct wavelength to assign to each amplitude. - As indicated in
step 735, thecomputer 202 can correct the spectral data for effects ascribable to open air, such as absorption due to atmospheric constituents, for example gases such as water vapor, carbon dioxide, and others that have strong absorption at characteristic wavelengths. -
Step 740 indicates that thecomputer 202 can correct for instrument-induced features by dividing an observed spectrum by an instrument function. The instrument function is obtained by dividing a known, accurate spectrum, such as a NIST-raceable tungsten lamp spectrum, by the observed spectrum recorded for illumination from such a lamp passing through the instrument of FIGS. 1 and 2. Dividing a first spectrum by a second spectrum involves dividing the respective amplitudes of the first spectrum by the corresponding amplitudes for the second spectrum and recording the result of each such division in a file as a function of the respective wavelengths, such as the instrument function. -
Step 745 indicates that thecomputer 202 can truncate a spectrum to limit the data saved to a file as amplitudes corresponding to the reduced set of wavelengths, rather than all the wavelengths that the spectral instrument of FIGS. 1-2 is capable of recording. The truncation is performed to avoid saving data that has no significance, such as data corresponding to amplitudes having zero intensity for wavelengths beyond some predetermined value. In some embodiments, the operator can use thekeyboard 206, or another input mechanism, to indicate one or both wavelength limits of the truncated wavelength range to be retained. - As indicated at
step 750, thecomputer 202 can reduce the number of amplitudes, each amplitude corresponding to a selected wavelength, that are used to characterize a spectrum. In some embodiments, the number of amplitudes used to characterize a spectrum is fifty (50). In principle, as few as three amplitudes at three wavelengths may be sufficient to characterize a reflectance spectrum as representing a test specimen comprising healthy normal squamous cells as distinguished from other tissue types having other states of health. - As indicated at
step 755, thecomputer 202 can normalize the reduced spectral data using a system and method called mean normalization. Mean normalization involves determining a mean value at each wavelength of interest for reference reflectance spectra and subtracting the mean values so determined at a particular wavelength of interest from the amplitude of the test spectrum (or spectra) at the same wavelength. - In one embodiment, at
step 760, where the metric to be used in classifying a test specimen is a Mahalanaobis distance, thecomputer 202 performs a mathematical procedure intended to guarantee that a matrix used in further analytical steps is capable of being inverted. Matrix inversion is a mathematical process well known in the matrix mathematical arts. In one embodiment, the matrix that is computed is called a Friedman matrix. The data used in the calculation of the Friedman matrix is obtained from the stored data recorded in machine-readable format. The step of computing the appropriate Friedman matrix can be performed at any time after the reference spectral data is available. - Computation of the Mahalanobis distance requires the inversion of a weighting matrix. One approach (i.e., Linear Discriminant Analysis) utilizes the inverse of the pooled within-groups covariance while another method (Quadratic Discriminant Analysis) employs the inverse of each within-group covariance. When a “large” number of wavelengths are used (e.g., for large p), either of the aforementioned matrices can be singular and hence cannot be inverted. Therefore, an alternate weighting matrix called the Friedman matrix is used.
-
-
-
- Where other metrics are used to classify a test spectrum and a test specimen, the step770 can be replaced by the appropriate computation.
- As indicated at
step 760, thecomputer 202 computes a metric from each test spectrum (or from an average value representing a plurality of spectra, such as performed at step 725) to each characteristic N-dimensional value for the reference spectra recorded. In one embodiment, the metric can be a Mahalanobis distance, as indicated above. In other embodiments, the metric can be the square root of the sum of the squares of the differences in coordinates in the N-dimensional space, or the metric can be the Bhattacharyya distance. - At
step 765, thecomputer 202 examines the results obtained instep 760, and determines a classification for the test specimen, based on the metrics computed with respect to the test reflectance spectrum and a classification rule or relation. In one embodiment, the classification relation is that the condition of the test specimen is assigned as the condition corresponding to the reference spectrum constellation or set having the Mahalanobis shortest distance, provided that the shortest Mahalanobis distance is less than a pre-determined minimum distance. In one embodiment, if no Mahalanobis distance is less than a pre-determined minimum distance, the test spectrum is discarded as being incapable of being classified, or indeterminate. - In one embodiment, the test reflectance spectrum can be compared to multiple sets of reference spectra in a single comparison. In one embodiment, the computations can be repeated for different sets of reference conditions. For example, a test reflectance spectrum from a test specimen can be compared in a first computation to reference reflectance spectral data for normal squamous tissue and CIN II/III tissue, compared in a second computation to reference reflectance spectral data for normal squamous tissue and CIN I tissue, and compared in a third computation to reference reflectance spectral data for normal squamous tissue and metaplasia tissue. If the test reflectance spectrum is classified in each of the three comparisons as being more closely related to the reference spectra for normal squamous tissue, the test specimen can be classified by the
computer 202 as having normal health, and the classification process is complete. However, if the test reflectance spectrum is classified in either of the comparisons involving CIN I or CIN II/III as being less closely related to the reference spectra for normal squamous tissue than one of the other conditions or states of health (namely CIN I, or CIN II/III), thecomputer 202 can report that the state of health of the test specimen is not clearly that of normal squamous tissue, and that further analysis is in order. In one embodiment, the further analysis involves the recording and examination of reflectance spectra. - While the invention has been particularly shown and described with reference to specific preferred embodiments, it should be understood by those skilled in the art that various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims:
Claims (23)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/738,613 US6385484B2 (en) | 1998-12-23 | 2000-12-15 | Spectroscopic system employing a plurality of data types |
US10/071,932 US20020133073A1 (en) | 1998-12-23 | 2002-02-08 | Spectroscopic system employing a plurality of data types |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11376198P | 1998-12-23 | 1998-12-23 | |
US09/470,071 US6411838B1 (en) | 1998-12-23 | 1999-12-22 | Systems and methods for optical examination of samples |
US09/738,613 US6385484B2 (en) | 1998-12-23 | 2000-12-15 | Spectroscopic system employing a plurality of data types |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/470,071 Continuation-In-Part US6411838B1 (en) | 1998-12-23 | 1999-12-22 | Systems and methods for optical examination of samples |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/071,932 Continuation US20020133073A1 (en) | 1998-12-23 | 2002-02-08 | Spectroscopic system employing a plurality of data types |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010020132A1 true US20010020132A1 (en) | 2001-09-06 |
US6385484B2 US6385484B2 (en) | 2002-05-07 |
Family
ID=22351348
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/470,071 Expired - Lifetime US6411838B1 (en) | 1998-12-23 | 1999-12-22 | Systems and methods for optical examination of samples |
US09/738,481 Expired - Lifetime US6421553B1 (en) | 1998-12-23 | 2000-12-15 | Spectral data classification of samples |
US09/738,613 Expired - Lifetime US6385484B2 (en) | 1998-12-23 | 2000-12-15 | Spectroscopic system employing a plurality of data types |
US10/071,932 Abandoned US20020133073A1 (en) | 1998-12-23 | 2002-02-08 | Spectroscopic system employing a plurality of data types |
US10/178,772 Expired - Fee Related US6760613B2 (en) | 1998-12-23 | 2002-06-24 | Substantially monostatic, substantially confocal optical systems for examination of samples |
US10/870,672 Abandoned US20050033186A1 (en) | 1998-12-23 | 2004-06-17 | Substantially monostatic, substantially confocal optical systems for examination of samples |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/470,071 Expired - Lifetime US6411838B1 (en) | 1998-12-23 | 1999-12-22 | Systems and methods for optical examination of samples |
US09/738,481 Expired - Lifetime US6421553B1 (en) | 1998-12-23 | 2000-12-15 | Spectral data classification of samples |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/071,932 Abandoned US20020133073A1 (en) | 1998-12-23 | 2002-02-08 | Spectroscopic system employing a plurality of data types |
US10/178,772 Expired - Fee Related US6760613B2 (en) | 1998-12-23 | 2002-06-24 | Substantially monostatic, substantially confocal optical systems for examination of samples |
US10/870,672 Abandoned US20050033186A1 (en) | 1998-12-23 | 2004-06-17 | Substantially monostatic, substantially confocal optical systems for examination of samples |
Country Status (6)
Country | Link |
---|---|
US (6) | US6411838B1 (en) |
EP (1) | EP1161178A2 (en) |
JP (1) | JP2002533142A (en) |
AU (1) | AU759282B2 (en) |
CA (1) | CA2356623C (en) |
WO (1) | WO2000037917A2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060147665A1 (en) * | 2004-12-31 | 2006-07-06 | Julio Duran | Method for making ePTFE and structure containing such ePTFE. such as a vascular graft |
US7316904B1 (en) | 2004-06-30 | 2008-01-08 | Chromodynamics, Inc. | Automated pap screening using optical detection of HPV with or without multispectral imaging |
US20140228714A1 (en) * | 2011-01-18 | 2014-08-14 | Holland Bloorview Kids Rehabilitation Hospital | Method and device for swallowing impairment detection |
WO2017161097A1 (en) * | 2016-03-16 | 2017-09-21 | Ohio State Innovation Foundation | System and method for the discrimination of tissues using a fast infrared cancer probe |
US11848094B2 (en) | 2022-04-08 | 2023-12-19 | Ohio State Innovation Foundation | Multidimensional optical tissue classification and display |
Families Citing this family (187)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010041843A1 (en) * | 1999-02-02 | 2001-11-15 | Mark Modell | Spectral volume microprobe arrays |
US6826422B1 (en) * | 1997-01-13 | 2004-11-30 | Medispectra, Inc. | Spectral volume microprobe arrays |
WO2000037917A2 (en) | 1998-12-23 | 2000-06-29 | Medispectra, Inc. | Systems and methods for optical examination of samples |
JP2000275757A (en) * | 1999-03-24 | 2000-10-06 | Fuji Photo Film Co Ltd | Method and device for evaluating image |
US7299080B2 (en) * | 1999-10-08 | 2007-11-20 | Sensys Medical, Inc. | Compact apparatus for noninvasive measurement of glucose through near-infrared spectroscopy |
WO2000068683A1 (en) * | 1999-05-10 | 2000-11-16 | Tomoya Sato | Method and apparatus for determining the type and/or condition of disease and method and apparatus for screening drug |
US7280866B1 (en) * | 1999-10-06 | 2007-10-09 | National Research Council Of Canada | Non-invasive screening of skin diseases by visible/near-infrared spectroscopy |
US6902935B2 (en) * | 1999-12-15 | 2005-06-07 | Medispectra, Inc. | Methods of monitoring effects of chemical agents on a sample |
US20050089923A9 (en) * | 2000-01-07 | 2005-04-28 | Levinson Douglas A. | Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds |
US7108970B2 (en) * | 2000-01-07 | 2006-09-19 | Transform Pharmaceuticals, Inc. | Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state |
US20050118637A9 (en) * | 2000-01-07 | 2005-06-02 | Levinson Douglas A. | Method and system for planning, performing, and assessing high-throughput screening of multicomponent chemical compositions and solid forms of compounds |
US6977723B2 (en) * | 2000-01-07 | 2005-12-20 | Transform Pharmaceuticals, Inc. | Apparatus and method for high-throughput preparation and spectroscopic classification and characterization of compositions |
WO2001051919A2 (en) * | 2000-01-07 | 2001-07-19 | Transform Pharmaceuticals, Inc. | High-throughput formation, identification, and analysis of diverse solid-forms |
US20070020662A1 (en) * | 2000-01-07 | 2007-01-25 | Transform Pharmaceuticals, Inc. | Computerized control of high-throughput experimental processing and digital analysis of comparative samples for a compound of interest |
US20070021929A1 (en) * | 2000-01-07 | 2007-01-25 | Transform Pharmaceuticals, Inc. | Computing methods for control of high-throughput experimental processing, digital analysis, and re-arraying comparative samples in computer-designed arrays |
US20050095696A9 (en) * | 2000-01-07 | 2005-05-05 | Lemmo Anthony V. | Apparatus and method for high-throughput preparation and characterization of compositions |
GB0008563D0 (en) * | 2000-04-07 | 2000-05-24 | Cambridge Discovery Chemistry | Investigating different physical and/or chemical forms of materials |
US7606608B2 (en) * | 2000-05-02 | 2009-10-20 | Sensys Medical, Inc. | Optical sampling interface system for in-vivo measurement of tissue |
US20060211931A1 (en) * | 2000-05-02 | 2006-09-21 | Blank Thomas B | Noninvasive analyzer sample probe interface method and apparatus |
US7519406B2 (en) * | 2004-04-28 | 2009-04-14 | Sensys Medical, Inc. | Noninvasive analyzer sample probe interface method and apparatus |
US6530882B1 (en) * | 2000-06-30 | 2003-03-11 | Inner Vision Imaging, L.L.C. | Endoscope having microscopic and macroscopic magnification |
DE60137046D1 (en) * | 2000-07-13 | 2009-01-29 | Univ Virginia Commonwealth | USE OF ULTRAVIOLET, NAHULTRAVIOLET, AND NEAR-FRAROT RESONANT RMS SPECTROSCOPY AND FLUORESIS SPECTROSCOPY FOR TISSUE STUDY OF SHOCK, CRITICAL DISEASES OR OTHER ILLNESS STATES |
US20020123112A1 (en) * | 2000-11-13 | 2002-09-05 | Genoptix | Methods for increasing detection sensitivity in optical dielectric sorting systems |
US6936811B2 (en) * | 2000-11-13 | 2005-08-30 | Genoptix, Inc. | Method for separating micro-particles |
US20020160470A1 (en) * | 2000-11-13 | 2002-10-31 | Genoptix | Methods and apparatus for generating and utilizing linear moving optical gradients |
US20030007894A1 (en) * | 2001-04-27 | 2003-01-09 | Genoptix | Methods and apparatus for use of optical forces for identification, characterization and/or sorting of particles |
US20020121443A1 (en) * | 2000-11-13 | 2002-09-05 | Genoptix | Methods for the combined electrical and optical identification, characterization and/or sorting of particles |
US6839661B2 (en) * | 2000-12-15 | 2005-01-04 | Medispectra, Inc. | System for normalizing spectra |
US6636769B2 (en) | 2000-12-18 | 2003-10-21 | Biosense, Inc. | Telemetric medical system and method |
US6652464B2 (en) | 2000-12-18 | 2003-11-25 | Biosense, Inc. | Intracardiac pressure monitoring method |
US6783499B2 (en) * | 2000-12-18 | 2004-08-31 | Biosense, Inc. | Anchoring mechanism for implantable telemetric medical sensor |
US6638231B2 (en) | 2000-12-18 | 2003-10-28 | Biosense, Inc. | Implantable telemetric medical sensor and method |
US20060129329A1 (en) * | 2001-04-09 | 2006-06-15 | Kobylecki Ryszard J | Investigating different physical and/or chemical forms of materials |
US20030124516A1 (en) * | 2001-04-27 | 2003-07-03 | Genoptix, Inc. | Method of using optical interrogation to determine a biological property of a cell or population of cells |
US20030194755A1 (en) * | 2001-04-27 | 2003-10-16 | Genoptix, Inc. | Early detection of apoptotic events and apoptosis using optophoretic analysis |
US20040023310A1 (en) * | 2001-04-27 | 2004-02-05 | Genoptix, Inc | Quantitative determination of protein kinase C activation using optophoretic analysis |
US20040009540A1 (en) * | 2001-04-27 | 2004-01-15 | Genoptix, Inc | Detection and evaluation of cancer cells using optophoretic analysis |
US7822621B1 (en) | 2001-05-16 | 2010-10-26 | Perot Systems Corporation | Method of and system for populating knowledge bases using rule based systems and object-oriented software |
US7831442B1 (en) | 2001-05-16 | 2010-11-09 | Perot Systems Corporation | System and method for minimizing edits for medical insurance claims processing |
US7956996B2 (en) * | 2007-02-14 | 2011-06-07 | Chemimage Corporation | Distinguishing between invasive ductal carcinoma and invasive lobular carcinoma using raman molecular imaging |
US20030065477A1 (en) * | 2001-08-30 | 2003-04-03 | Opdyke John D. | Two-sample permutation tests |
EP1428032A2 (en) * | 2001-09-07 | 2004-06-16 | Transform Pharmaceuticals, Inc. | Apparatus and method for high-throughput preparation and characterization of compositions |
JP3944383B2 (en) * | 2001-11-16 | 2007-07-11 | 株式会社日立製作所 | Cardiac magnetic field measuring device |
FI113497B (en) * | 2002-02-28 | 2004-04-30 | Vaisala Oyj | light Radar |
US20070149868A1 (en) * | 2002-03-08 | 2007-06-28 | Blank Thomas B | Method and Apparatus for Photostimulation Enhanced Analyte Property Estimation |
US20050187439A1 (en) * | 2003-03-07 | 2005-08-25 | Blank Thomas B. | Sampling interface system for in-vivo estimation of tissue analyte concentration |
US8718738B2 (en) * | 2002-03-08 | 2014-05-06 | Glt Acquisition Corp. | Method and apparatus for coupling a sample probe with a sample site |
US7697966B2 (en) * | 2002-03-08 | 2010-04-13 | Sensys Medical, Inc. | Noninvasive targeting system method and apparatus |
US8504128B2 (en) * | 2002-03-08 | 2013-08-06 | Glt Acquisition Corp. | Method and apparatus for coupling a channeled sample probe to tissue |
JP4189322B2 (en) * | 2002-03-08 | 2008-12-03 | センシス メディカル インク | Compact instrument for non-invasive measurement of glucose by near infrared spectroscopy |
US7440786B2 (en) * | 2002-03-08 | 2008-10-21 | Sensys Medical, Inc. | Method and apparatus for presentation of noninvasive glucose concentration information |
US20050054908A1 (en) * | 2003-03-07 | 2005-03-10 | Blank Thomas B. | Photostimulation method and apparatus in combination with glucose determination |
US7725144B2 (en) * | 2002-04-04 | 2010-05-25 | Veralight, Inc. | Determination of disease state using raman spectroscopy of tissue |
US8131332B2 (en) * | 2002-04-04 | 2012-03-06 | Veralight, Inc. | Determination of a measure of a glycation end-product or disease state using tissue fluorescence of various sites |
US20030211461A1 (en) * | 2002-05-01 | 2003-11-13 | Genoptix, Inc | Optophoretic detection of durgs exhibiting inhibitory effect on Bcr-Abl positive tumor cells |
US20040033539A1 (en) * | 2002-05-01 | 2004-02-19 | Genoptix, Inc | Method of using optical interrogation to determine a biological property of a cell or population of cells |
US7459696B2 (en) * | 2003-04-18 | 2008-12-02 | Schomacker Kevin T | Methods and apparatus for calibrating spectral data |
US7136518B2 (en) * | 2003-04-18 | 2006-11-14 | Medispectra, Inc. | Methods and apparatus for displaying diagnostic data |
US6818903B2 (en) * | 2002-07-09 | 2004-11-16 | Medispectra, Inc. | Method and apparatus for identifying spectral artifacts |
US7309867B2 (en) * | 2003-04-18 | 2007-12-18 | Medispectra, Inc. | Methods and apparatus for characterization of tissue samples |
US7469160B2 (en) * | 2003-04-18 | 2008-12-23 | Banks Perry S | Methods and apparatus for evaluating image focus |
US6933154B2 (en) * | 2002-07-09 | 2005-08-23 | Medispectra, Inc. | Optimal windows for obtaining optical data for characterization of tissue samples |
US20040208385A1 (en) * | 2003-04-18 | 2004-10-21 | Medispectra, Inc. | Methods and apparatus for visually enhancing images |
US6768918B2 (en) | 2002-07-10 | 2004-07-27 | Medispectra, Inc. | Fluorescent fiberoptic probe for tissue health discrimination and method of use thereof |
US7373198B2 (en) * | 2002-07-12 | 2008-05-13 | Bionova Technologies Inc. | Method and apparatus for the estimation of anesthetic depth using wavelet analysis of the electroencephalogram |
US7060075B2 (en) * | 2002-07-18 | 2006-06-13 | Biosense, Inc. | Distal targeting of locking screws in intramedullary nails |
US6925322B2 (en) * | 2002-07-25 | 2005-08-02 | Biophan Technologies, Inc. | Optical MRI catheter system |
US20040064053A1 (en) * | 2002-09-30 | 2004-04-01 | Chang Sung K. | Diagnostic fluorescence and reflectance |
US20040121474A1 (en) * | 2002-12-19 | 2004-06-24 | Genoptix, Inc | Detection and evaluation of chemically-mediated and ligand-mediated t-cell activation using optophoretic analysis |
US20040121307A1 (en) * | 2002-12-19 | 2004-06-24 | Genoptix, Inc | Early detection of cellular differentiation using optophoresis |
US7419483B2 (en) * | 2003-02-07 | 2008-09-02 | Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California | Surgical drain with positioning and protective features |
JP4041421B2 (en) * | 2003-03-25 | 2008-01-30 | 独立行政法人理化学研究所 | Raman probe and Raman scattering measuring apparatus using the same |
US7184626B1 (en) * | 2003-04-07 | 2007-02-27 | Luxtera, Inc | Wafer-level testing of optical and optoelectronic chips |
WO2005004714A1 (en) | 2003-07-01 | 2005-01-20 | The Regents Of The University Of Michigan | Method and apparatus for diagnosing bone tissue conditions |
US20050119587A1 (en) * | 2003-07-01 | 2005-06-02 | University Of Michigan | Method and apparatus for evaluating connective tissue conditions |
JP4533382B2 (en) * | 2003-08-28 | 2010-09-01 | セルラ・インコーポレイテッド | Integrated structure for microfluidic analysis and sorting |
US20070234300A1 (en) * | 2003-09-18 | 2007-10-04 | Leake David W | Method and Apparatus for Performing State-Table Driven Regression Testing |
US7379769B2 (en) | 2003-09-30 | 2008-05-27 | Sunnybrook Health Sciences Center | Hybrid imaging method to monitor medical device delivery and patient support for use in the method |
US20080077005A1 (en) * | 2004-08-12 | 2008-03-27 | Piron Cameron A | System and Method for Multimodality Breast Imaging |
US7970452B2 (en) * | 2003-09-30 | 2011-06-28 | Hologic, Inc. | Open architecture imaging apparatus and coil system for magnetic resonance imaging |
US7908690B2 (en) * | 2003-09-30 | 2011-03-22 | Sentinelle Medical, Inc. | Supine patient support for medical imaging |
DE10355150B4 (en) * | 2003-11-26 | 2021-01-14 | Leica Microsystems Cms Gmbh | Method and system for the analysis of co-localizations |
WO2005052558A1 (en) * | 2003-11-28 | 2005-06-09 | Bc Cancer Agency | Multimodal detection of tissue abnormalities based on raman and background fluorescence spectroscopy |
JP4601965B2 (en) | 2004-01-09 | 2010-12-22 | 浜松ホトニクス株式会社 | Laser processing method and laser processing apparatus |
JP4509578B2 (en) * | 2004-01-09 | 2010-07-21 | 浜松ホトニクス株式会社 | Laser processing method and laser processing apparatus |
JP4598407B2 (en) * | 2004-01-09 | 2010-12-15 | 浜松ホトニクス株式会社 | Laser processing method and laser processing apparatus |
US20050215876A1 (en) * | 2004-03-25 | 2005-09-29 | Eastman Kodak Company | Method and system for automatic image adjustment for in vivo image diagnosis |
US20080033275A1 (en) * | 2004-04-28 | 2008-02-07 | Blank Thomas B | Method and Apparatus for Sample Probe Movement Control |
US8868147B2 (en) * | 2004-04-28 | 2014-10-21 | Glt Acquisition Corp. | Method and apparatus for controlling positioning of a noninvasive analyzer sample probe |
US7697576B2 (en) * | 2004-05-05 | 2010-04-13 | Chem Image Corporation | Cytological analysis by raman spectroscopic imaging |
WO2006019991A2 (en) * | 2004-07-15 | 2006-02-23 | Cheminage Corporation | Method and apparatus for multimodal detection |
US7254501B1 (en) * | 2004-12-10 | 2007-08-07 | Ahura Corporation | Spectrum searching method that uses non-chemical qualities of the measurement |
US7298938B2 (en) * | 2004-10-01 | 2007-11-20 | University Of Washington | Configuration memory for a scanning beam device |
US8929688B2 (en) * | 2004-10-01 | 2015-01-06 | University Of Washington | Remapping methods to reduce distortions in images |
JP2006145810A (en) * | 2004-11-19 | 2006-06-08 | Canon Inc | Automatic focusing apparatus, laser beam machining apparatus and laser beam cutter |
FR2878424B1 (en) * | 2004-11-26 | 2008-02-01 | Oreal | METHOD FOR OBSERVING A BIOLOGICAL TISSUE, IN PARTICULAR HUMAN SKIN |
EP1830705B1 (en) * | 2004-11-26 | 2010-12-29 | L'Oréal | A method of observing biological tissue, in particular human skin |
US7854705B2 (en) * | 2004-12-16 | 2010-12-21 | Olga Pawluczyk | Ex vivo verification of biopsy tissue samples |
US8244332B2 (en) * | 2004-12-22 | 2012-08-14 | Siemens Medical Solutions Usa, Inc. | Three-dimensional breast anatomy imaging system |
US7784697B2 (en) | 2004-12-23 | 2010-08-31 | University Of Washington | Methods of driving a scanning beam device to achieve high frame rates |
US7159782B2 (en) * | 2004-12-23 | 2007-01-09 | University Of Washington | Methods of driving a scanning beam device to achieve high frame rates |
EP1838206B1 (en) * | 2005-01-21 | 2018-04-04 | Optiscan Pty Ltd | Fibre bundle confocal endomicroscope |
US7189961B2 (en) * | 2005-02-23 | 2007-03-13 | University Of Washington | Scanning beam device with detector assembly |
US20060206018A1 (en) * | 2005-03-04 | 2006-09-14 | Alan Abul-Haj | Method and apparatus for noninvasive targeting |
US7219038B2 (en) * | 2005-03-22 | 2007-05-15 | College Of William And Mary | Automatic peak identification method |
US20060226231A1 (en) * | 2005-03-29 | 2006-10-12 | University Of Washington | Methods and systems for creating sequential color images |
US7627059B2 (en) * | 2005-04-05 | 2009-12-01 | Samsung Electronics Co., Ltd. | Method of robust timing detection and carrier frequency offset estimation for OFDM systems |
US7616699B2 (en) * | 2005-04-12 | 2009-11-10 | Samsung Electronics Co., Ltd. | Method of soft bit metric calculation with direct matrix inversion MIMO detection |
US8582089B2 (en) * | 2006-06-09 | 2013-11-12 | Chemimage Corporation | System and method for combined raman, SWIR and LIBS detection |
US7679740B2 (en) * | 2005-07-14 | 2010-03-16 | Chemimage Corporation | Method and apparatus for multimodal detection |
WO2007123555A2 (en) | 2005-07-14 | 2007-11-01 | Chemimage Corporation | Time and space resolved standoff hyperspectral ied explosives lidar detector |
US7395967B2 (en) * | 2005-07-21 | 2008-07-08 | University Of Washington | Methods and systems for counterbalancing a scanning beam device |
US7312879B2 (en) * | 2005-08-23 | 2007-12-25 | University Of Washington | Distance determination in a scanned beam image capture device |
CN102007513A (en) * | 2005-08-26 | 2011-04-06 | 卡姆特有限公司 | Device and method for inspecting an object |
US7729749B2 (en) * | 2005-09-01 | 2010-06-01 | The Regents Of The University Of Michigan | Method and apparatus for evaluating connective tissue conditions |
US20070178067A1 (en) * | 2005-11-09 | 2007-08-02 | John Maier | System and method for cytological analysis by raman spectroscopic imaging |
US7450228B2 (en) | 2005-11-09 | 2008-11-11 | Chemimage Corporation | Spectral imaging of biofilms |
US20070161876A1 (en) | 2005-11-18 | 2007-07-12 | Spectrx, Inc. | Method and apparatus for rapid detection and diagnosis of tissue abnormalities |
US7751506B2 (en) | 2005-12-01 | 2010-07-06 | Samsung Electronics Co., Ltd. | Method for the soft bit metric calculation with linear MIMO detection for LDPC codes |
EP1969325A2 (en) * | 2005-12-23 | 2008-09-17 | Chemimage Corporation | Chemical imaging explosives (chimed) optical sensor |
US8368880B2 (en) * | 2005-12-23 | 2013-02-05 | Chemimage Corporation | Chemical imaging explosives (CHIMED) optical sensor using SWIR |
US8379197B2 (en) * | 2006-01-05 | 2013-02-19 | Chemimage Corporation | Spectroscopic systems and methods for classifying and pharmaceutically treating cells |
EP1971838A2 (en) * | 2006-01-05 | 2008-09-24 | Chemimage Corporation | System and method for classifying cells and the pharmaceutical treatment of such cells using raman spectroscopy |
US8081304B2 (en) | 2006-07-31 | 2011-12-20 | Visualant, Inc. | Method, apparatus, and article to facilitate evaluation of objects using electromagnetic energy |
US8076630B2 (en) | 2006-07-31 | 2011-12-13 | Visualant, Inc. | System and method of evaluating an object using electromagnetic energy |
US7996173B2 (en) * | 2006-07-31 | 2011-08-09 | Visualant, Inc. | Method, apparatus, and article to facilitate distributed evaluation of objects using electromagnetic energy |
US7680373B2 (en) * | 2006-09-13 | 2010-03-16 | University Of Washington | Temperature adjustment in scanning beam devices |
US7447415B2 (en) * | 2006-12-15 | 2008-11-04 | University Of Washington | Attaching optical fibers to actuator tubes with beads acting as spacers and adhesives |
US7738762B2 (en) * | 2006-12-15 | 2010-06-15 | University Of Washington | Attaching optical fibers to actuator tubes with beads acting as spacers and adhesives |
US8305432B2 (en) * | 2007-01-10 | 2012-11-06 | University Of Washington | Scanning beam device calibration |
US7990532B2 (en) | 2007-01-16 | 2011-08-02 | Chemimage Corporation | Method and apparatus for multimodal detection |
WO2008100582A2 (en) * | 2007-02-14 | 2008-08-21 | Chemimage Corporation | Spectroscopic system and method for predicting outcome of disease |
US8155417B2 (en) | 2007-03-27 | 2012-04-10 | Hologic, Inc. | Post-acquisition adaptive reconstruction of MRI data |
US7583872B2 (en) * | 2007-04-05 | 2009-09-01 | University Of Washington | Compact scanning fiber device |
US7608842B2 (en) * | 2007-04-26 | 2009-10-27 | University Of Washington | Driving scanning fiber devices with variable frequency drive signals |
US20080281159A1 (en) * | 2007-05-08 | 2008-11-13 | University Of Washington | Coordinating image acquisition among multiple endoscopes |
US20080281207A1 (en) * | 2007-05-08 | 2008-11-13 | University Of Washington | Image acquisition through filtering in multiple endoscope systems |
US8212884B2 (en) * | 2007-05-22 | 2012-07-03 | University Of Washington | Scanning beam device having different image acquisition modes |
US8437587B2 (en) * | 2007-07-25 | 2013-05-07 | University Of Washington | Actuating an optical fiber with a piezoelectric actuator and detecting voltages generated by the piezoelectric actuator |
GB2451442B (en) * | 2007-07-30 | 2013-03-06 | Lein Applied Diagnostics Ltd | Optical measurement apparatus and method therefor |
US20090036759A1 (en) * | 2007-08-01 | 2009-02-05 | Ault Timothy E | Collapsible noninvasive analyzer method and apparatus |
EP2183382A1 (en) * | 2007-08-08 | 2010-05-12 | Chemimage Corporation | Raman difference spectra based disease classification |
US7522813B1 (en) * | 2007-10-04 | 2009-04-21 | University Of Washington | Reducing distortion in scanning fiber devices |
WO2009064746A2 (en) * | 2007-11-12 | 2009-05-22 | Cornell University | Multi-path, multi-magnification, non-confocal fluorescence emission endoscopy apparatus and methods |
US7940047B2 (en) | 2007-11-23 | 2011-05-10 | Sentinelle Medical, Inc. | Microcontroller system for identifying RF coils in the bore of a magnetic resonance imaging system |
US8411922B2 (en) * | 2007-11-30 | 2013-04-02 | University Of Washington | Reducing noise in images acquired with a scanning beam device |
WO2009126888A2 (en) | 2008-04-10 | 2009-10-15 | Services Petroliers Schlumberger | Method for characterizing a geological formation traversed by a borehole |
US8725477B2 (en) * | 2008-04-10 | 2014-05-13 | Schlumberger Technology Corporation | Method to generate numerical pseudocores using borehole images, digital rock samples, and multi-point statistics |
US20110004080A1 (en) * | 2008-04-11 | 2011-01-06 | Glucovista, Llc | Method for non-invasive analysis of a substance concentration within a body |
US8611975B2 (en) * | 2009-10-28 | 2013-12-17 | Gluco Vista, Inc. | Apparatus and method for non-invasive measurement of a substance within a body |
CA3162577C (en) * | 2008-05-20 | 2023-09-26 | University Health Network | Device and method for fluorescence-based imaging and monitoring |
US8954133B1 (en) | 2008-08-08 | 2015-02-10 | The United States Of America As Represented By The Department Of Veterans Affairs | Spectroscopic detection of brain damage |
US8077386B2 (en) | 2008-10-22 | 2011-12-13 | Microbrightfield, Inc. | Movable objective lens assembly for an optical microscope and optical microscopes having such an assembly |
JP5768041B2 (en) | 2009-04-07 | 2015-08-26 | カソリック ヘルスケア ウェスト | Method of operating a uterine electrical stimulation system |
US20110004447A1 (en) * | 2009-07-01 | 2011-01-06 | Schlumberger Technology Corporation | Method to build 3D digital models of porous media using transmitted laser scanning confocal mircoscopy and multi-point statistics |
US8311788B2 (en) * | 2009-07-01 | 2012-11-13 | Schlumberger Technology Corporation | Method to quantify discrete pore shapes, volumes, and surface areas using confocal profilometry |
US8747331B2 (en) * | 2009-06-23 | 2014-06-10 | Hologic, Inc. | Variable angle guide holder for a biopsy guide plug |
WO2011017706A1 (en) * | 2009-08-07 | 2011-02-10 | Catholic Healthcare West | Cervical, fetal-membrane, and amniotic examination and assessment device and method |
US9103714B2 (en) * | 2009-10-06 | 2015-08-11 | Chemimage Corporation | System and methods for explosives detection using SWIR |
US8903466B2 (en) | 2009-10-28 | 2014-12-02 | Glucovista Inc. | Apparatus and method for non-invasive measurement of a substance within a body |
US9019262B2 (en) * | 2009-11-27 | 2015-04-28 | Hologic, Inc. | Systems and methods for tracking positions between imaging modalities and transforming a displayed three-dimensional image corresponding to a position and orientation of a probe |
US8988680B2 (en) | 2010-04-30 | 2015-03-24 | Chemimage Technologies Llc | Dual polarization with liquid crystal tunable filters |
US7884933B1 (en) | 2010-05-05 | 2011-02-08 | Revolutionary Business Concepts, Inc. | Apparatus and method for determining analyte concentrations |
US9151769B2 (en) * | 2010-07-02 | 2015-10-06 | Idexx Laboratories, Inc. | Automated calibration method and system for a diagnostic analyzer |
JP5604248B2 (en) * | 2010-09-28 | 2014-10-08 | 富士フイルム株式会社 | Endoscopic image display device |
US9872983B2 (en) | 2010-10-27 | 2018-01-23 | Dignity Health | Uterine electrical stimulation system and method |
WO2012058289A2 (en) | 2010-10-27 | 2012-05-03 | Dignity Health | Uterine electrical stimulation system and method |
US9913596B2 (en) | 2010-11-25 | 2018-03-13 | Invivo Corporation | Systems and methods for MRI guided trans-orifice and transperineal intervention apparatus with adjustable biopsy needle insertion |
KR101691156B1 (en) * | 2010-12-14 | 2016-12-30 | 삼성전자주식회사 | Optical system having integrated illumination and imaging systems and 3D image acquisition apparatus including the optical system |
US8888207B2 (en) | 2012-02-10 | 2014-11-18 | Visualant, Inc. | Systems, methods and articles related to machine-readable indicia and symbols |
WO2013177061A1 (en) * | 2012-05-21 | 2013-11-28 | The Regents Of The University Of Colorado, A Body Corporate | Three-dimensional mapping and therapy of prostate cancer |
US9814448B2 (en) | 2012-05-21 | 2017-11-14 | Precision Biopsy, Inc. | Three-dimensional optical imaging and therapy of prostate cancer |
US9076246B2 (en) | 2012-08-09 | 2015-07-07 | Hologic, Inc. | System and method of overlaying images of different modalities |
JP2014106116A (en) * | 2012-11-28 | 2014-06-09 | Shimadzu Corp | Plastic determination device |
US9316581B2 (en) | 2013-02-04 | 2016-04-19 | Visualant, Inc. | Method, apparatus, and article to facilitate evaluation of substances using electromagnetic energy |
DE112014000683B4 (en) * | 2013-02-05 | 2023-10-05 | Paul Fournier | Fiber optic probe for long distance spectroscopy |
US9041920B2 (en) | 2013-02-21 | 2015-05-26 | Visualant, Inc. | Device for evaluation of fluids using electromagnetic energy |
WO2014165003A1 (en) | 2013-03-12 | 2014-10-09 | Visualant, Inc. | Systems and methods for fluid analysis using electromagnetic energy |
WO2014150274A1 (en) | 2013-03-15 | 2014-09-25 | Hologic, Inc. | System and method for reviewing and analyzing cytological specimens |
MX2014011990A (en) | 2013-10-04 | 2015-05-28 | Tidi Products Llc | Sheath for a medical or dental instrument. |
CN105814423B (en) * | 2013-12-16 | 2018-06-29 | 日本电信电话株式会社 | End face observation device |
JP2016028229A (en) * | 2014-07-08 | 2016-02-25 | キヤノン株式会社 | Data processing apparatus, data display system having the same, sample information acquisition system, data processing method, program, and storage medium |
JP6769949B2 (en) | 2014-07-24 | 2020-10-14 | ユニバーシティー ヘルス ネットワーク | Data collection and analysis for diagnostic purposes |
DE102014013179A1 (en) * | 2014-09-04 | 2016-03-10 | Diehl Bgt Defence Gmbh & Co. Kg | Targeting device for a guided missile |
DE102016112010B4 (en) * | 2016-03-22 | 2021-03-04 | Jenoptik Industrial Metrology Germany Gmbh | Bore inspection device |
WO2020051539A1 (en) * | 2018-09-06 | 2020-03-12 | Philipe Aldahir | Turf playability testing |
US11328435B2 (en) * | 2020-06-08 | 2022-05-10 | KLA Corp. | Image alignment setup for specimens with intra- and inter-specimen variations using unsupervised learning and adaptive database generation methods |
Family Cites Families (249)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3013467A (en) | 1957-11-07 | 1961-12-19 | Minsky Marvin | Microscopy apparatus |
US3632865A (en) * | 1969-12-23 | 1972-01-04 | Bell Telephone Labor Inc | Predictive video encoding using measured subject velocity |
US3809072A (en) | 1971-10-07 | 1974-05-07 | Med General Inc | Sterile sheath apparatus for fiber optic illuminator with compatible lens |
IT985204B (en) * | 1972-05-26 | 1974-11-30 | Adelman Stuart Lee | IMPROVEMENT IN ENDOSCOPES AND THE LIKE |
US3890462A (en) | 1974-04-17 | 1975-06-17 | Bell Telephone Labor Inc | Speed and direction indicator for video systems |
US3963019A (en) | 1974-11-25 | 1976-06-15 | Quandt Robert S | Ocular testing method and apparatus |
US4017192A (en) | 1975-02-06 | 1977-04-12 | Neotec Corporation | Optical analysis of biomedical specimens |
US4071020A (en) * | 1976-06-03 | 1978-01-31 | Xienta, Inc. | Apparatus and methods for performing in-vivo measurements of enzyme activity |
GB1595422A (en) | 1977-04-28 | 1981-08-12 | Nat Res Dev | Scaning microscopes |
FR2430754A1 (en) | 1978-07-13 | 1980-02-08 | Groux Jean | ULTRAVIOLET ENDOSCOPE |
US4218703A (en) | 1979-03-16 | 1980-08-19 | Bell Telephone Laboratories, Incorporated | Technique for estimation of displacement and/or velocity of objects in video scenes |
US4357075A (en) | 1979-07-02 | 1982-11-02 | Hunter Thomas M | Confocal reflector system |
US4254421A (en) | 1979-12-05 | 1981-03-03 | Communications Satellite Corporation | Integrated confocal electromagnetic wave lens and feed antenna system |
DE2951459C2 (en) | 1979-12-20 | 1984-03-29 | Heimann Gmbh, 6200 Wiesbaden | Optical arrangement for a smoke detector based on the light scattering principle |
US4515165A (en) * | 1980-02-04 | 1985-05-07 | Energy Conversion Devices, Inc. | Apparatus and method for detecting tumors |
ATE23752T1 (en) | 1980-08-21 | 1986-12-15 | Oriel Scient Ltd | OPTICAL ANALYZER. |
CA1201198A (en) | 1982-02-01 | 1986-02-25 | Sony Corporation | Method and apparatus for compensating for tape jitter during recording and reproducing of a video signal andpcm audio signal |
US4619268A (en) | 1983-08-11 | 1986-10-28 | Vitacomm, Ltd. | Esophageal stethoscope and vital signs monitor system |
US5139025A (en) | 1983-10-14 | 1992-08-18 | Somanetics Corporation | Method and apparatus for in vivo optical spectroscopic examination |
SU1223092A1 (en) | 1984-03-11 | 1986-04-07 | Предприятие П/Я Р-6681 | Small-angle nephelometer |
SE455736B (en) | 1984-03-15 | 1988-08-01 | Sarastro Ab | PROCEDURE KIT AND MICROPHOTOMETRATION AND ADDITIONAL IMAGE COMPOSITION |
US4641352A (en) * | 1984-07-12 | 1987-02-03 | Paul Fenster | Misregistration correction |
US4662360A (en) | 1984-10-23 | 1987-05-05 | Intelligent Medical Systems, Inc. | Disposable speculum |
US5179936A (en) | 1984-10-23 | 1993-01-19 | Intelligent Medical Systems, Inc. | Disposable speculum with membrane bonding ring |
US4646722A (en) * | 1984-12-10 | 1987-03-03 | Opielab, Inc. | Protective endoscope sheath and method of installing same |
US4803049A (en) * | 1984-12-12 | 1989-02-07 | The Regents Of The University Of California | pH-sensitive optrode |
US5199431A (en) | 1985-03-22 | 1993-04-06 | Massachusetts Institute Of Technology | Optical needle for spectroscopic diagnosis |
US5693043A (en) | 1985-03-22 | 1997-12-02 | Massachusetts Institute Of Technology | Catheter for laser angiosurgery |
CA1279901C (en) * | 1985-03-22 | 1991-02-05 | Carter Kittrell | Catheter for laser angiosurgery |
US5042494A (en) | 1985-11-13 | 1991-08-27 | Alfano Robert R | Method and apparatus for detecting cancerous tissue using luminescence excitation spectra |
US4930516B1 (en) | 1985-11-13 | 1998-08-04 | Laser Diagnostic Instr Inc | Method for detecting cancerous tissue using visible native luminescence |
JPS62138819A (en) | 1985-12-13 | 1987-06-22 | Hitachi Ltd | Scanning type laser microscope |
JPS62247232A (en) | 1986-04-21 | 1987-10-28 | Agency Of Ind Science & Technol | Fluorescence measuring apparatus |
US5011243A (en) | 1986-09-16 | 1991-04-30 | Laser Precision Corporation | Reflectance infrared microscope having high radiation throughput |
US4852955A (en) | 1986-09-16 | 1989-08-01 | Laser Precision Corporation | Microscope for use in modular FTIR spectrometer system |
US4741326A (en) | 1986-10-01 | 1988-05-03 | Fujinon, Inc. | Endoscope disposable sheath |
US4891829A (en) | 1986-11-19 | 1990-01-02 | Exxon Research And Engineering Company | Method and apparatus for utilizing an electro-optic detector in a microtomography system |
NL8603108A (en) | 1986-12-08 | 1988-07-01 | Philips Nv | MICROSALE. |
US4810875A (en) | 1987-02-02 | 1989-03-07 | Wyatt Technology Corporation | Method and apparatus for examining the interior of semi-opaque objects |
CA1300369C (en) | 1987-03-24 | 1992-05-12 | Timothy P. Dabbs | Distance measuring device |
US5235457A (en) | 1987-09-24 | 1993-08-10 | Washington University | Kit for converting a standard microscope into a single aperture confocal scanning epi-illumination microscope |
US4945478A (en) | 1987-11-06 | 1990-07-31 | Center For Innovative Technology | Noninvasive medical imaging system and method for the identification and 3-D display of atherosclerosis and the like |
US4800571A (en) * | 1988-01-11 | 1989-01-24 | Tektronix, Inc. | Timing jitter measurement display |
US4844617A (en) | 1988-01-20 | 1989-07-04 | Tencor Instruments | Confocal measuring microscope with automatic focusing |
FR2626383B1 (en) | 1988-01-27 | 1991-10-25 | Commissariat Energie Atomique | EXTENDED FIELD SCAN AND DEPTH CONFOCAL OPTICAL MICROSCOPY AND DEVICES FOR CARRYING OUT THE METHOD |
US4997242A (en) | 1988-03-07 | 1991-03-05 | Medical Research Council | Achromatic scanning system |
US4934811A (en) | 1988-04-01 | 1990-06-19 | Syntex (U.S.A.) Inc. | Apparatus and method for detection of fluorescence or light scatter |
US5032720A (en) | 1988-04-21 | 1991-07-16 | White John G | Confocal imaging system |
US4877033A (en) | 1988-05-04 | 1989-10-31 | Seitz Jr H Michael | Disposable needle guide and examination sheath for transvaginal ultrasound procedures |
DE8808299U1 (en) | 1988-06-25 | 1989-07-20 | Effner Gmbh, 1000 Berlin, De | |
DE68929464T2 (en) | 1988-07-13 | 2003-11-20 | Optiscan Pty Ltd | scanning microscope |
WO1990000358A1 (en) | 1988-07-15 | 1990-01-25 | Ellis Frampton E Iii | Shoe with naturally contoured sole |
CA1325537C (en) | 1988-08-01 | 1993-12-28 | Timothy Peter Dabbs | Confocal microscope |
US5036853A (en) | 1988-08-26 | 1991-08-06 | Polartechnics Ltd. | Physiological probe |
US4972258A (en) | 1989-07-31 | 1990-11-20 | E. I. Du Pont De Nemours And Company | Scanning laser microscope system and methods of use |
US5101825A (en) * | 1988-10-28 | 1992-04-07 | Blackbox, Inc. | Method for noninvasive intermittent and/or continuous hemoglobin, arterial oxygen content, and hematocrit determination |
US5205291A (en) * | 1988-11-08 | 1993-04-27 | Health Research, Inc. | In vivo fluorescence photometer |
US5419323A (en) | 1988-12-21 | 1995-05-30 | Massachusetts Institute Of Technology | Method for laser induced fluorescence of tissue |
US5022757A (en) | 1989-01-23 | 1991-06-11 | Modell Mark D | Heterodyne system and method for sensing a target substance |
US4878485A (en) | 1989-02-03 | 1989-11-07 | Adair Edwin Lloyd | Rigid video endoscope with heat sterilizable sheath |
US5003979A (en) | 1989-02-21 | 1991-04-02 | University Of Virginia | System and method for the noninvasive identification and display of breast lesions and the like |
US5421337A (en) | 1989-04-14 | 1995-06-06 | Massachusetts Institute Of Technology | Spectral diagnosis of diseased tissue |
US5201318A (en) | 1989-04-24 | 1993-04-13 | Rava Richard P | Contour mapping of spectral diagnostics |
JPH0378720A (en) | 1989-08-22 | 1991-04-03 | Nikon Corp | Confocal laser scanning microscope |
US5065008A (en) | 1989-10-18 | 1991-11-12 | Fuji Photo Film Co., Ltd. | Scanning microscope and scanning mechanism for the same |
DE8912757U1 (en) | 1989-10-27 | 1989-12-07 | Fa. Carl Zeiss, 7920 Heidenheim, De | |
US4979498A (en) | 1989-10-30 | 1990-12-25 | Machida Incorporated | Video cervicoscope system |
US5034613A (en) | 1989-11-14 | 1991-07-23 | Cornell Research Foundation, Inc. | Two-photon laser microscopy |
US5257617A (en) | 1989-12-25 | 1993-11-02 | Asahi Kogaku Kogyo Kabushiki Kaisha | Sheathed endoscope and sheath therefor |
US5028802A (en) | 1990-01-11 | 1991-07-02 | Eye Research Institute Of Retina Foundation | Imaging apparatus and methods utilizing scannable microlaser source |
US5274240A (en) | 1990-01-12 | 1993-12-28 | The Regents Of The University Of California | Capillary array confocal fluorescence scanner and method |
US5091652A (en) | 1990-01-12 | 1992-02-25 | The Regents Of The University Of California | Laser excited confocal microscope fluorescence scanner and method |
DE69118429T2 (en) | 1990-01-26 | 1996-09-12 | Canon Kk | Method of measuring a species using fluorescent light |
JPH0742401Y2 (en) | 1990-02-01 | 1995-10-04 | 株式会社町田製作所 | Endoscope cover |
JPH03101903U (en) | 1990-02-01 | 1991-10-23 | ||
US5074306A (en) | 1990-02-22 | 1991-12-24 | The General Hospital Corporation | Measurement of burn depth in skin |
EP0444689B1 (en) | 1990-03-01 | 1995-12-20 | X-Rite, Inc. | A compensation method adapted for use in color measuring apparatus |
US5083220A (en) | 1990-03-22 | 1992-01-21 | Tandem Scanning Corporation | Scanning disks for use in tandem scanning reflected light microscopes and other optical systems |
JP2613118B2 (en) | 1990-04-10 | 1997-05-21 | 富士写真フイルム株式会社 | Confocal scanning microscope |
US5048946A (en) | 1990-05-15 | 1991-09-17 | Phoenix Laser Systems, Inc. | Spectral division of reflected light in complex optical diagnostic and therapeutic systems |
EP0458601B1 (en) | 1990-05-22 | 1996-08-28 | Research Development Corporation Of Japan | Method of and apparatus for measuring spectral absorption in opaque specimens and method of and apparatus for measuring microscopic absorption distribution |
GB9014263D0 (en) | 1990-06-27 | 1990-08-15 | Dixon Arthur E | Apparatus and method for spatially- and spectrally- resolvedmeasurements |
GB9016587D0 (en) | 1990-07-27 | 1990-09-12 | Isis Innovation | Infra-red scanning microscopy |
US5324979A (en) | 1990-09-26 | 1994-06-28 | Futrex, Inc. | Method and means for generating synthetic spectra allowing quantitative measurement in near infrared measuring instruments |
US5239178A (en) | 1990-11-10 | 1993-08-24 | Carl Zeiss | Optical device with an illuminating grid and detector grid arranged confocally to an object |
US5168157A (en) | 1990-11-20 | 1992-12-01 | Fuji Photo Film Co., Ltd. | Scanning microscope with means for detecting a first and second polarized light beams along first and second optical receiving paths |
US5193525A (en) * | 1990-11-30 | 1993-03-16 | Vision Sciences | Antiglare tip in a sheath for an endoscope |
US5720293A (en) * | 1991-01-29 | 1998-02-24 | Baxter International Inc. | Diagnostic catheter with memory |
JP3103894B2 (en) * | 1991-02-06 | 2000-10-30 | ソニー株式会社 | Apparatus and method for correcting camera shake of video data |
US5261410A (en) * | 1991-02-07 | 1993-11-16 | Alfano Robert R | Method for determining if a tissue is a malignant tumor tissue, a benign tumor tissue, or a normal or benign tissue using Raman spectroscopy |
US5162641A (en) | 1991-02-19 | 1992-11-10 | Phoenix Laser Systems, Inc. | System and method for detecting, correcting and measuring depth movement of target tissue in a laser surgical system |
US5303026A (en) | 1991-02-26 | 1994-04-12 | The Regents Of The University Of California Los Alamos National Laboratory | Apparatus and method for spectroscopic analysis of scattering media |
US5260578A (en) | 1991-04-10 | 1993-11-09 | Mayo Foundation For Medical Education And Research | Confocal imaging system for visible and ultraviolet light |
DE4111903A1 (en) | 1991-04-12 | 1992-10-15 | Bayer Ag | SPECTROSCOPY-CORRECTED LIGHT-SCREEN MICROSCOPY |
US5257085A (en) | 1991-04-24 | 1993-10-26 | Kaman Aerospace Corporation | Spectrally dispersive imaging lidar system |
US5321501A (en) | 1991-04-29 | 1994-06-14 | Massachusetts Institute Of Technology | Method and apparatus for optical imaging with means for controlling the longitudinal range of the sample |
CA2042075C (en) * | 1991-05-08 | 2001-01-23 | Branko Palcic | Endoscopic imaging system |
ATE162037T1 (en) * | 1991-05-24 | 1998-01-15 | British Broadcasting Corp | VIDEO IMAGE PROCESSING |
JP2975719B2 (en) | 1991-05-29 | 1999-11-10 | オリンパス光学工業株式会社 | Confocal optics |
US5319200A (en) | 1991-06-05 | 1994-06-07 | Zeltex, Inc. | Rapid near-infrared measurement of nonhomogeneous samples |
US5201908A (en) | 1991-06-10 | 1993-04-13 | Endomedical Technologies, Inc. | Sheath for protecting endoscope from contamination |
US5313567A (en) | 1991-06-13 | 1994-05-17 | At&T Bell Laboratories | Arrangement for determining and displaying volumetric data in an imaging system |
US5237984A (en) | 1991-06-24 | 1993-08-24 | Xomed-Treace Inc. | Sheath for endoscope |
US5769792A (en) * | 1991-07-03 | 1998-06-23 | Xillix Technologies Corp. | Endoscopic imaging system for diseased tissue |
US5203328A (en) * | 1991-07-17 | 1993-04-20 | Georgia Tech Research Corporation | Apparatus and methods for quantitatively measuring molecular changes in the ocular lens |
US5162941A (en) | 1991-07-23 | 1992-11-10 | The Board Of Governors Of Wayne State University | Confocal microscope |
JPH0527177A (en) | 1991-07-25 | 1993-02-05 | Fuji Photo Film Co Ltd | Scanning type microscope |
JP3082346B2 (en) | 1991-09-12 | 2000-08-28 | 株式会社ニコン | Fluorescence confocal microscope |
US5383874A (en) * | 1991-11-08 | 1995-01-24 | Ep Technologies, Inc. | Systems for identifying catheters and monitoring their use |
US5467767A (en) * | 1991-11-25 | 1995-11-21 | Alfano; Robert R. | Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy |
JP3018687B2 (en) | 1991-12-12 | 2000-03-13 | 松下電器産業株式会社 | Scanning laser microscope |
US5253071A (en) | 1991-12-20 | 1993-10-12 | Sony Corporation Of America | Method and apparatus for stabilizing an image produced in a video camera |
US5398685A (en) | 1992-01-10 | 1995-03-21 | Wilk; Peter J. | Endoscopic diagnostic system and associated method |
US5284149A (en) | 1992-01-23 | 1994-02-08 | Dhadwal Harbans S | Method and apparatus for determining the physical characteristics of ocular tissue |
US5248876A (en) | 1992-04-21 | 1993-09-28 | International Business Machines Corporation | Tandem linear scanning confocal imaging system with focal volumes at different heights |
GB9213978D0 (en) | 1992-07-01 | 1992-08-12 | Skidmore Robert | Medical devices |
US5325846A (en) | 1992-07-27 | 1994-07-05 | Linvatec Corporation | Endoscopic draping apparatus and method |
US5609560A (en) | 1992-08-19 | 1997-03-11 | Olympus Optical Co., Ltd. | Medical operation device control system for controlling a operation devices accessed respectively by ID codes |
US5704892A (en) | 1992-09-01 | 1998-01-06 | Adair; Edwin L. | Endoscope with reusable core and disposable sheath with passageways |
US5306902A (en) | 1992-09-01 | 1994-04-26 | International Business Machines Corporation | Confocal method and apparatus for focusing in projection lithography |
US5402768A (en) | 1992-09-01 | 1995-04-04 | Adair; Edwin L. | Endoscope with reusable core and disposable sheath with passageways |
CH684556A5 (en) | 1992-09-14 | 1994-10-14 | Cerberus Ag | Optical Smoke Detector. |
US5285490A (en) * | 1992-10-22 | 1994-02-08 | Eastman Kodak Company | Imaging combination for detecting soft tissue anomalies |
US5337734A (en) | 1992-10-29 | 1994-08-16 | Advanced Polymers, Incorporated | Disposable sheath with optically transparent window formed continuously integral therewith |
US5469853A (en) | 1992-12-11 | 1995-11-28 | Tetrad Corporation | Bendable ultrasonic probe and sheath for use therewith |
US5418797A (en) | 1993-01-15 | 1995-05-23 | The United States Of America As Represented By The Secretary Of The Navy | Time gated imaging through scattering material using polarization and stimulated raman amplification |
US5294799A (en) | 1993-02-01 | 1994-03-15 | Aslund Nils R D | Apparatus for quantitative imaging of multiple fluorophores |
US5545121A (en) | 1993-02-02 | 1996-08-13 | Olympus Optical Co., Ltd. | Cover-type endoscope apparatus |
US5415157A (en) | 1993-02-05 | 1995-05-16 | Welcome; Steven | Damage preventing endoscope head cover |
US5536236A (en) | 1993-02-12 | 1996-07-16 | Olympus Optical Co., Ltd. | Covered endoscope system |
US5419311A (en) | 1993-02-18 | 1995-05-30 | Olympus Optical Co., Ltd. | Endoscope apparatus of a type having cover for covering the endoscope |
US5556367A (en) | 1993-03-05 | 1996-09-17 | Olympus Optical Co., Ltd. | Cover type endoscope apparatus |
US5458132A (en) | 1993-03-15 | 1995-10-17 | Olympus Optical Co., Ltd. | Endoscope cover-sheathed endoscope system |
US5458133A (en) | 1993-03-15 | 1995-10-17 | Olympus Optical Co., Ltd. | Cover type endoscope apparatus |
US5551945A (en) | 1993-03-16 | 1996-09-03 | Olympus Optical Co., Ltd. | Endoscope system including endoscope and protection cover |
US5424543A (en) | 1993-04-19 | 1995-06-13 | Surface Optics Corporation | Imaging spectroradiometer |
US5413108A (en) | 1993-04-21 | 1995-05-09 | The Research Foundation Of City College Of New York | Method and apparatus for mapping a tissue sample for and distinguishing different regions thereof based on luminescence measurements of cancer-indicative native fluorophor |
US5421339A (en) | 1993-05-12 | 1995-06-06 | Board Of Regents, The University Of Texas System | Diagnosis of dysplasia using laser induced fluoroescence |
US5817015A (en) | 1993-06-22 | 1998-10-06 | Adair; Edwin L. | Endoscope with reusable core and disposable sheath with passageways |
US5596992A (en) | 1993-06-30 | 1997-01-28 | Sandia Corporation | Multivariate classification of infrared spectra of cell and tissue samples |
US5995645A (en) | 1993-08-18 | 1999-11-30 | Applied Spectral Imaging Ltd. | Method of cancer cell detection |
US5598842A (en) | 1993-09-03 | 1997-02-04 | Toa Medical Electronics Co., Ltd. | Non-invasive blood analyzer and method using the same |
US5496259A (en) * | 1993-09-13 | 1996-03-05 | Welch Allyn, Inc. | Sterile protective sheath and drape for video laparoscope and method of use |
US5412563A (en) * | 1993-09-16 | 1995-05-02 | General Electric Company | Gradient image segmentation method |
US5587832A (en) | 1993-10-20 | 1996-12-24 | Biophysica Technologies, Inc. | Spatially light modulated confocal microscope and method |
ZA948393B (en) | 1993-11-01 | 1995-06-26 | Polartechnics Ltd | Method and apparatus for tissue type recognition |
US5725477A (en) | 1993-11-18 | 1998-03-10 | Asahi Kogaku Kogyo Kabushiki Kaisha | Front end structure of endoscope |
JP3257209B2 (en) | 1993-11-30 | 2002-02-18 | ソニー株式会社 | Digital signal recording circuit |
US5983125A (en) | 1993-12-13 | 1999-11-09 | The Research Foundation Of City College Of New York | Method and apparatus for in vivo examination of subcutaneous tissues inside an organ of a body using optical spectroscopy |
US5406939A (en) | 1994-02-14 | 1995-04-18 | Bala; Harry | Endoscope sheath |
US5493444A (en) | 1994-04-28 | 1996-02-20 | The United States Of America As Represented By The Secretary Of The Air Force | Photorefractive two-beam coupling nonlinear joint transform correlator |
US5529235A (en) | 1994-04-28 | 1996-06-25 | Ethicon Endo-Surgery, Inc. | Identification device for surgical instrument |
US5450857A (en) | 1994-05-19 | 1995-09-19 | Board Of Regents, The University Of Texas System | Method for the diagnosis of cervical changes |
JP3379821B2 (en) | 1994-05-31 | 2003-02-24 | オリンパス光学工業株式会社 | Endoscope |
EP0689045A1 (en) | 1994-06-23 | 1995-12-27 | Koninklijke Philips Electronics N.V. | Multi-frequency modulation spectrometer |
JPH0843204A (en) * | 1994-06-23 | 1996-02-16 | Philips Electron Nv | Multiplex-frequency spectrometer |
US5477382A (en) | 1994-08-05 | 1995-12-19 | Northrop Grumman Corporation | Optical correlator system |
JP2802244B2 (en) | 1994-08-29 | 1998-09-24 | オリンパス光学工業株式会社 | Endoscope sheath |
US5599717A (en) * | 1994-09-02 | 1997-02-04 | Martin Marietta Energy Systems, Inc. | Advanced synchronous luminescence system |
US5579773A (en) | 1994-09-30 | 1996-12-03 | Martin Marietta Energy Systems, Inc. | Laser-induced differential normalized fluorescence method for cancer diagnosis |
JP3732865B2 (en) * | 1995-01-18 | 2006-01-11 | ペンタックス株式会社 | Endoscope device |
DE19504174A1 (en) | 1995-02-07 | 1996-08-08 | Siemens Ag | Method for the spectroscopic examination of a biological tissue |
US5894340A (en) * | 1995-02-17 | 1999-04-13 | The Regents Of The University Of California | Method for quantifying optical properties of the human lens |
JP3490817B2 (en) | 1995-03-13 | 2004-01-26 | ペンタックス株式会社 | Endoscope tip |
US5991653A (en) | 1995-03-14 | 1999-11-23 | Board Of Regents, The University Of Texas System | Near-infrared raman spectroscopy for in vitro and in vivo detection of cervical precancers |
US5697373A (en) | 1995-03-14 | 1997-12-16 | Board Of Regents, The University Of Texas System | Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies |
US5735276A (en) * | 1995-03-21 | 1998-04-07 | Lemelson; Jerome | Method and apparatus for scanning and evaluating matter |
US5699795A (en) | 1995-03-31 | 1997-12-23 | Board Of Regents, The University Of Texas System | Optical probe for the detection of cervical neoplasia using fluorescence spectroscopy and apparatus incorporating same |
US5612540A (en) * | 1995-03-31 | 1997-03-18 | Board Of Regents, The University Of Texas Systems | Optical method for the detection of cervical neoplasias using fluorescence spectroscopy |
JP3543027B2 (en) | 1995-04-10 | 2004-07-14 | オリンパス株式会社 | Curved sheath for probe |
JP3476958B2 (en) | 1995-04-12 | 2003-12-10 | アークレイ株式会社 | A method for stabilizing spectra in spectrometry. |
US5690106A (en) | 1995-06-30 | 1997-11-25 | Siemens Corporate Research, Inc. | Flexible image registration for rotational angiography |
US5813987A (en) | 1995-08-01 | 1998-09-29 | Medispectra, Inc. | Spectral volume microprobe for analysis of materials |
US6104945A (en) | 1995-08-01 | 2000-08-15 | Medispectra, Inc. | Spectral volume microprobe arrays |
US5713364A (en) | 1995-08-01 | 1998-02-03 | Medispectra, Inc. | Spectral volume microprobe analysis of materials |
US6411835B1 (en) | 1997-01-13 | 2002-06-25 | Medispectra, Inc. | Spectral volume microprobe arrays |
US5730701A (en) | 1995-09-12 | 1998-03-24 | Olympus Optical Co., Ltd. | Endoscope |
JPH0998938A (en) * | 1995-10-04 | 1997-04-15 | Fuji Photo Optical Co Ltd | Protector of insertion part of endoscope |
US6146897A (en) | 1995-11-13 | 2000-11-14 | Bio-Rad Laboratories | Method for the detection of cellular abnormalities using Fourier transform infrared spectroscopy |
US5795632A (en) | 1996-02-06 | 1998-08-18 | Parker Laboratories | Protective cover set for a medical probe |
US5647368A (en) | 1996-02-28 | 1997-07-15 | Xillix Technologies Corp. | Imaging system for detecting diseased tissue using native fluorsecence in the gastrointestinal and respiratory tract |
JP3796635B2 (en) * | 1996-03-06 | 2006-07-12 | 富士写真フイルム株式会社 | Fluorescence detection device |
US5865726A (en) | 1996-03-27 | 1999-02-02 | Asahi Kogaku Kogyo Kabushiki Kaisha | Front end structure of side-view type endoscope |
US5717209A (en) * | 1996-04-29 | 1998-02-10 | Petrometrix Ltd. | System for remote transmission of spectral information through communication optical fibers for real-time on-line hydrocarbons process analysis by near infra red spectroscopy |
US5807248A (en) | 1996-05-15 | 1998-09-15 | Ohmeda Inc. | Medical monitoring probe with modular device housing |
US5860913A (en) | 1996-05-16 | 1999-01-19 | Olympus Optical Co., Ltd. | Endoscope whose distal cover can be freely detachably attached to main distal part thereof with high positioning precision |
US5931779A (en) * | 1996-06-06 | 1999-08-03 | Wisconsin Alumni Research Foundation | Real-time in-vivo measurement of myoglobin oxygen saturation |
US5773835A (en) | 1996-06-07 | 1998-06-30 | Rare Earth Medical, Inc. | Fiber optic spectroscopy |
WO1997050003A1 (en) * | 1996-06-26 | 1997-12-31 | Morphometrix Technologies Inc. | Confocal ultrasonic imaging system |
US5842995A (en) | 1996-06-28 | 1998-12-01 | Board Of Regents, The Univerisity Of Texas System | Spectroscopic probe for in vivo measurement of raman signals |
US5685822A (en) | 1996-08-08 | 1997-11-11 | Vision-Sciences, Inc. | Endoscope with sheath retaining device |
US5791346A (en) | 1996-08-22 | 1998-08-11 | Western Research Company, Inc. | Colposcope device and method for measuring areas of cervical lesions |
US6119031A (en) | 1996-11-21 | 2000-09-12 | Boston Scientific Corporation | Miniature spectrometer |
US5768333A (en) | 1996-12-02 | 1998-06-16 | Philips Electronics N.A. Corporation | Mass detection in digital radiologic images using a two stage classifier |
CA2192036A1 (en) | 1996-12-04 | 1998-06-04 | Harvey Lui | Fluorescence scope system for dermatologic diagnosis |
US6847490B1 (en) * | 1997-01-13 | 2005-01-25 | Medispectra, Inc. | Optical probe accessory device for use in vivo diagnostic procedures |
JP3654325B2 (en) * | 1997-02-13 | 2005-06-02 | 富士写真フイルム株式会社 | Fluorescence detection device |
US5941834A (en) | 1997-03-17 | 1999-08-24 | Polartechnics Limited | Sheath for a side view probe |
US5855551A (en) | 1997-03-17 | 1999-01-05 | Polartechnics Limited | Integral sheathing apparatus for tissue recognition probes |
US5830146A (en) | 1997-03-17 | 1998-11-03 | Polartechnics Limited | Sheathed probes for tissue type recognition |
US5929985A (en) | 1997-03-18 | 1999-07-27 | Sandia Corporation | Multispectral imaging probe |
US5920399A (en) | 1997-03-18 | 1999-07-06 | Sandia Corporation | Multispectral imaging method and apparatus |
US5989184A (en) | 1997-04-04 | 1999-11-23 | Medtech Research Corporation | Apparatus and method for digital photography useful in cervical cancer detection |
US6008889A (en) | 1997-04-16 | 1999-12-28 | Zeng; Haishan | Spectrometer system for diagnosis of skin disease |
FR2763721B1 (en) * | 1997-05-21 | 1999-08-06 | Inst Nat Rech Inf Automat | ELECTRONIC IMAGE PROCESSING DEVICE FOR DETECTING DIMENSIONAL VARIATIONS |
US6124597A (en) | 1997-07-07 | 2000-09-26 | Cedars-Sinai Medical Center | Method and devices for laser induced fluorescence attenuation spectroscopy |
US6096065A (en) | 1997-09-29 | 2000-08-01 | Boston Scientific Corporation | Sheath for tissue spectroscopy |
US6317617B1 (en) | 1997-07-25 | 2001-11-13 | Arch Development Corporation | Method, computer program product, and system for the automated analysis of lesions in magnetic resonance, mammogram and ultrasound images |
US6058322A (en) | 1997-07-25 | 2000-05-02 | Arch Development Corporation | Methods for improving the accuracy in differential diagnosis on radiologic examinations |
US5921926A (en) | 1997-07-28 | 1999-07-13 | University Of Central Florida | Three dimensional optical imaging colposcopy |
WO1999020313A1 (en) * | 1997-10-20 | 1999-04-29 | The Board Of Regents, The University Of Texas System | Acetic acid as a contrast agent in reflectance confocal imaging of tissue |
US6091985A (en) * | 1998-01-23 | 2000-07-18 | Research Foundation Of City College Of New York | Detection of cancer and precancerous conditions in tissues and/or cells using native fluorescence excitation spectroscopy |
ATE391451T1 (en) * | 1998-01-26 | 2008-04-15 | Massachusetts Inst Technology | ENDOSCOPE FOR CAPTURE FLUORESCENCE IMAGES |
US6364829B1 (en) * | 1999-01-26 | 2002-04-02 | Newton Laboratories, Inc. | Autofluorescence imaging system for endoscopy |
AU3102699A (en) * | 1998-03-19 | 1999-10-11 | Board Of Regents, The University Of Texas System | Fiber-optic confocal imaging apparatus and methods of use |
US6505059B1 (en) * | 1998-04-06 | 2003-01-07 | The General Hospital Corporation | Non-invasive tissue glucose level monitoring |
US6285639B1 (en) | 1998-04-29 | 2001-09-04 | Sony Corporation | On-the-fly of jitter during optical disc mastering/recording |
US6571118B1 (en) * | 1998-05-04 | 2003-05-27 | Board Of Regents, The University Of Texas System | Combined fluorescence and reflectance spectroscopy |
US6246479B1 (en) * | 1998-06-08 | 2001-06-12 | Lj Laboratories, L.L.C. | Integrated spectrometer assembly and methods |
US6246471B1 (en) | 1998-06-08 | 2001-06-12 | Lj Laboratories, Llc | Apparatus and method for measuring optical characteristics of an object |
US6243601B1 (en) * | 1998-09-18 | 2001-06-05 | Abund Ottokar Wist | Transillumination imaging instrumentation with scattered light discrimination |
US6377842B1 (en) * | 1998-09-22 | 2002-04-23 | Aurora Optics, Inc. | Method for quantitative measurement of fluorescent and phosphorescent drugs within tissue utilizing a fiber optic probe |
US6169817B1 (en) | 1998-11-04 | 2001-01-02 | University Of Rochester | System and method for 4D reconstruction and visualization |
US6507747B1 (en) * | 1998-12-02 | 2003-01-14 | Board Of Regents, The University Of Texas System | Method and apparatus for concomitant structural and biochemical characterization of tissue |
JP2002532181A (en) | 1998-12-23 | 2002-10-02 | メディスペクトラ, インコーポレイテッド | Optical method and system for cervical screening |
WO2000037917A2 (en) | 1998-12-23 | 2000-06-29 | Medispectra, Inc. | Systems and methods for optical examination of samples |
US6556720B1 (en) * | 1999-05-24 | 2003-04-29 | Ge Medical Systems Global Technology Company Llc | Method and apparatus for enhancing and correcting digital images |
US6697666B1 (en) * | 1999-06-22 | 2004-02-24 | Board Of Regents, The University Of Texas System | Apparatus for the characterization of tissue of epithelial lined viscus |
US6208887B1 (en) * | 1999-06-24 | 2001-03-27 | Richard H. Clarke | Catheter-delivered low resolution Raman scattering analyzing system for detecting lesions |
US6717668B2 (en) * | 2000-03-07 | 2004-04-06 | Chemimage Corporation | Simultaneous imaging and spectroscopy apparatus |
JP2001157658A (en) | 1999-12-02 | 2001-06-12 | Fuji Photo Film Co Ltd | Fluorescent image display device |
US6902935B2 (en) * | 1999-12-15 | 2005-06-07 | Medispectra, Inc. | Methods of monitoring effects of chemical agents on a sample |
GR1004180B (en) * | 2000-03-28 | 2003-03-11 | ����������� ����� ��������� (����) | Method and system for characterization and mapping of tissue lesions |
US6377841B1 (en) * | 2000-03-31 | 2002-04-23 | Vanderbilt University | Tumor demarcation using optical spectroscopy |
US6312385B1 (en) | 2000-05-01 | 2001-11-06 | Ge Medical Systems Global Technology Company, Llc | Method and apparatus for automatic detection and sizing of cystic objects |
JP4191884B2 (en) * | 2000-08-18 | 2008-12-03 | ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー | Image processing method, image processing apparatus, and image photographing apparatus |
US6718055B1 (en) * | 2000-12-05 | 2004-04-06 | Koninklijke Philips Electronics, N.V. | Temporal and spatial correction for perfusion quantification system |
US6839661B2 (en) * | 2000-12-15 | 2005-01-04 | Medispectra, Inc. | System for normalizing spectra |
USD453964S1 (en) * | 2001-02-09 | 2002-02-26 | Medispectra, Inc. | Sheath for cervical optical probe |
USD453963S1 (en) * | 2001-02-09 | 2002-02-26 | Medispectra, Inc. | Sheath for cervical optical probe |
USD453962S1 (en) * | 2001-02-09 | 2002-02-26 | Medispectra, Inc. | Sheath for cervical optical probe |
USD460821S1 (en) | 2001-02-09 | 2002-07-23 | Medispectra, Inc. | Sheath for cervical optical probe |
USD453832S1 (en) * | 2001-02-09 | 2002-02-19 | Medispectra, Inc. | Sheath for cervical optical probe |
US6818903B2 (en) * | 2002-07-09 | 2004-11-16 | Medispectra, Inc. | Method and apparatus for identifying spectral artifacts |
US6933154B2 (en) * | 2002-07-09 | 2005-08-23 | Medispectra, Inc. | Optimal windows for obtaining optical data for characterization of tissue samples |
US7282723B2 (en) * | 2002-07-09 | 2007-10-16 | Medispectra, Inc. | Methods and apparatus for processing spectral data for use in tissue characterization |
US6768918B2 (en) * | 2002-07-10 | 2004-07-27 | Medispectra, Inc. | Fluorescent fiberoptic probe for tissue health discrimination and method of use thereof |
US7103401B2 (en) * | 2002-07-10 | 2006-09-05 | Medispectra, Inc. | Colonic polyp discrimination by tissue fluorescence and fiberoptic probe |
ATE476908T1 (en) * | 2003-04-18 | 2010-08-15 | Medispectra Inc | SYSTEM AND DIAGNOSTIC METHOD FOR OPTICAL DETECTION OF SUSPICIOUS AREAS IN A TISSUE SAMPLE |
-
1999
- 1999-12-22 WO PCT/US1999/031001 patent/WO2000037917A2/en not_active Application Discontinuation
- 1999-12-22 EP EP99968963A patent/EP1161178A2/en not_active Withdrawn
- 1999-12-22 AU AU27153/00A patent/AU759282B2/en not_active Ceased
- 1999-12-22 JP JP2000589927A patent/JP2002533142A/en active Pending
- 1999-12-22 US US09/470,071 patent/US6411838B1/en not_active Expired - Lifetime
- 1999-12-22 CA CA002356623A patent/CA2356623C/en not_active Expired - Fee Related
-
2000
- 2000-12-15 US US09/738,481 patent/US6421553B1/en not_active Expired - Lifetime
- 2000-12-15 US US09/738,613 patent/US6385484B2/en not_active Expired - Lifetime
-
2002
- 2002-02-08 US US10/071,932 patent/US20020133073A1/en not_active Abandoned
- 2002-06-24 US US10/178,772 patent/US6760613B2/en not_active Expired - Fee Related
-
2004
- 2004-06-17 US US10/870,672 patent/US20050033186A1/en not_active Abandoned
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7316904B1 (en) | 2004-06-30 | 2008-01-08 | Chromodynamics, Inc. | Automated pap screening using optical detection of HPV with or without multispectral imaging |
US20060147665A1 (en) * | 2004-12-31 | 2006-07-06 | Julio Duran | Method for making ePTFE and structure containing such ePTFE. such as a vascular graft |
US20140228714A1 (en) * | 2011-01-18 | 2014-08-14 | Holland Bloorview Kids Rehabilitation Hospital | Method and device for swallowing impairment detection |
US9687191B2 (en) * | 2011-01-18 | 2017-06-27 | Holland Bloorview Kids Rehabilitation Hospital | Method and device for swallowing impairment detection |
US11033221B2 (en) | 2011-01-18 | 2021-06-15 | University Health Network | Method and device for swallowing impairment detection |
WO2017161097A1 (en) * | 2016-03-16 | 2017-09-21 | Ohio State Innovation Foundation | System and method for the discrimination of tissues using a fast infrared cancer probe |
US11678802B2 (en) | 2016-03-16 | 2023-06-20 | Ohio State Innovation Foundation | System and method for the discrimination of tissues using a fast infrared cancer probe |
US11848094B2 (en) | 2022-04-08 | 2023-12-19 | Ohio State Innovation Foundation | Multidimensional optical tissue classification and display |
Also Published As
Publication number | Publication date |
---|---|
US6411838B1 (en) | 2002-06-25 |
US20020183626A1 (en) | 2002-12-05 |
US20050033186A1 (en) | 2005-02-10 |
US6760613B2 (en) | 2004-07-06 |
CA2356623C (en) | 2005-10-18 |
US6421553B1 (en) | 2002-07-16 |
AU759282B2 (en) | 2003-04-10 |
EP1161178A2 (en) | 2001-12-12 |
JP2002533142A (en) | 2002-10-08 |
WO2000037917A3 (en) | 2001-08-23 |
US6385484B2 (en) | 2002-05-07 |
US20020133073A1 (en) | 2002-09-19 |
CA2356623A1 (en) | 2000-06-29 |
WO2000037917A2 (en) | 2000-06-29 |
AU2715300A (en) | 2000-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6385484B2 (en) | Spectroscopic system employing a plurality of data types | |
US6818903B2 (en) | Method and apparatus for identifying spectral artifacts | |
US6839661B2 (en) | System for normalizing spectra | |
US8532750B2 (en) | Process and device for detection of precancer tissues with infrared spectroscopy | |
US6526299B2 (en) | Spectrum processing and processor | |
US7136518B2 (en) | Methods and apparatus for displaying diagnostic data | |
US7282723B2 (en) | Methods and apparatus for processing spectral data for use in tissue characterization | |
US7459696B2 (en) | Methods and apparatus for calibrating spectral data | |
US7309867B2 (en) | Methods and apparatus for characterization of tissue samples | |
JP4602765B2 (en) | Near-infrared spectroscopic analysis of blood vessel walls | |
US11678802B2 (en) | System and method for the discrimination of tissues using a fast infrared cancer probe | |
AU2002227343A1 (en) | System for normalizing spectra | |
US20040208385A1 (en) | Methods and apparatus for visually enhancing images | |
US20040209237A1 (en) | Methods and apparatus for characterization of tissue samples | |
JP2005534428A5 (en) | ||
CA2491703A1 (en) | Methods and apparatus for characterization of tissue samples | |
WO2003031954A1 (en) | Classification of samples | |
WO2007066589A1 (en) | Method and apparatus for examining and diagnosing life style-related disease using near-infrared spectroscopy | |
US20230194532A1 (en) | Quantum optics profiles for screening, diagnosis, and prognosis of diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MEDISPECTRA, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NORDSTROM, ROBERT J.;COSTA, PETER J.;HUI, KWONG;AND OTHERS;REEL/FRAME:011647/0936 Effective date: 20010316 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
AS | Assignment |
Owner name: LUMA IMAGING CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:EUCLIDSR PARTNERS IV, L.P.;EUCLIDSR PARTNERS, L.P.;EUCLIDSR BIOTECHNOLOGY PARTNERS, L.P.;SIGNING DATES FROM 20070907 TO 20070910;REEL/FRAME:025875/0643 Owner name: EUCLIDSR BIOTECHNOLOGY PARTNERS, L.P., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EUCLIDSR PARTNERS, LP, COLLATERAL AGENT;REEL/FRAME:025875/0623 Effective date: 20070907 Owner name: EUCLIDSR PARTNERS IV, L.P., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EUCLIDSR PARTNERS, LP, COLLATERAL AGENT;REEL/FRAME:025875/0623 Effective date: 20070907 Owner name: EUCLIDSR PARTNERS, LP, COLLATERAL AGENT, NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MEDISPECTRA, INC.;REEL/FRAME:025875/0603 Effective date: 20070830 Owner name: EUCLIDSR PARTNERS, L.P., NEW YORK Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EUCLIDSR PARTNERS, LP, COLLATERAL AGENT;REEL/FRAME:025875/0623 Effective date: 20070907 |
|
FPAY | Fee payment |
Year of fee payment: 12 |